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ABSTRACT 
Disorders of sex development (DSD) are an umbrella term for conditions where biological 
development of sex is affected. Included in this thesis are women with different DSD; women 
with congenital adrenal hyperplasia (CAH), a disorder causing androgen excess, women with 
complete androgen insensitivity (CAIS), a disorder of androgen action, and women with 
complete gonadal dysgenesis (CGD), a complete absence of testicular or ovarian development. 
Although the etiologies are different, living with a chronic condition is interlaced with continuous 
learning and new challenges. During the last decades research has focused on elucidating the 
genetic background in DSD and, the effect of androgens on psychosexual development. Thus, 
mental health issues and psychological outcomes need to be explored. Therefore, the overall 
aim of this thesis was to investigate psychological and psychiatric aspects regarding women with 
DSD. The methods used to achieve this aim were interview studies analyzed by qualitative 
content analysis (Studies I and II), matched case cohort study using the Swedish nationwide 
registries and 1:100 age-matched male and female controls (Study III), and a cross-sectional 
study using structured clinical interviews (MINI+) with women with CAIS and GD compared to 
women with premature ovarian insufficiency (POI) and age-matched controls (1:1). The findings 
from 13 interviews with women with CAH (Studies I and II), revealed that knowledge about 
CAH facilitates disclosure of information. Similarly, knowledge about one’s body facilitates the 
initiation of sexual activities. On the other hand, repeated genital examinations can threaten 
autonomy and lead to traumatic experiences. Participation in research was considered to be 
important to improve future caretaking, however, much research was not considered important 
for the individual patient. Participants identified as women, however, some participants did not 
feel feminine enough. Subsequent, motherhood was described as a confirmation of being a 
woman. Participants had shifting opinions as to what role CAH has played in their lives, and how 
it affected their experiences and views. Moreover, shame was fueled by experiences of exposure 
in interaction with health professionals, as well as parental shame, and a recurrent focus on 
evaluation and normality. In conclusion, all participants described their struggle to be seen as 
individuals. The specific objective of Study III and Study IV was to increase knowledge of 
psychiatric disorders among women with DSD. Linkage of Swedish registries with the National 
CAH Registry (Study III) showed an increased risk of psychiatric disorders among girls and 
women with CAH, and in particular substance use disorders, compared to population controls. 
Lastly, in Study IV, screening for psychiatric disorders with MINI+ revealed significantly 
increased frequencies of psychiatric disorders in women with CAIS and CGD compared to 
women with POI and population-derived controls. Thus, the increased frequencies reported in 
both Study III and Study IV, call for clinical attention to psychiatric symptoms in women with 
DSD. In conclusion, women with DSD are a diverse group of individuals with different needs and 
experiences. They have a higher risk for psychiatric disorders. By acknowledging this fact, health 
professionals can aid with age-appropriate information, information disclosure strategies, 
attention to psychiatric symptoms, and support, to help women with DSD reach the fullest 
possible physical and mental health. Furthermore, involvement of persons with a DSD in care and 
research may help to understand the variability in outcome. Moreover, increased awareness of 
DSD among health professionals, and the general public could eventually make life easier for 
persons with a DSD. 
 SAMMANFATTNING 
Disorders of sex development (DSD) är en övergripande term för tillstånd som påverkar biologisk 
könsutveckling. Den här avhandlingen inkluderar kvinnor med medfödd binjurebarkssvikt (CAH) 
som leder till överskott av androgener (t.ex. testosteron) och kvinnor med komplett androgen 
okänslighet (CAIS) som pga. dysfunktion i androgenreceptorer inte har någon effekt av 
androgener, samt kvinnor med komplett gonaddysgenesi (CGD) som har en medfödd påverkad 
utveckling av testiklar eller ovarier. Således är orsakerna till DSD olika men att leva med en 
kronisk sjukdom innebär ständigt lärande och nya utmaningar. De senaste decennierna har 
forskning kring DSD fokuserat på att förstå den bakomliggande genetiken samt att utforska 
androgeners påverkan på psykosexuell utveckling. Men för att förbättra omhändertagande behövs 
studier kring mental hälsa och vad som påverkar psykologiskt välbefinnande. Målet med 
avhandlingen var därför att fördjupa kunskaperna kring vilka psykiatriska och psykologiska 
aspekter som är viktiga för kvinnor med DSD. Metoderna som användes var intervjustudier med 
kvinnor med CAH (studie I och II) som analyserades med kvalitativ innehållsanalys, 
registerstudie där psykiatriska diagnoser i en kohort av kvinnor med CAH jämfördes med 1:100 
åldersmatchade kontroller (studie III) och till sist, en tvärsnittsstudie där en kortfattad 
standardiserad diagnostisk intervju (MINI+) användes för att studera förekomsten av 
psykiatriska symtom hos kvinnor med CAIS och CGD i jämförelse med kvinnor med prematur 
ovariell insufficiens (POI) och åldersmatchade kontroller (studie IV). Resultaten från intervjuer 
med kvinnor med CAH (I,II) visade att adekvat kunskap om CAH underlättade när 
informanterna skulle berätta om sitt tillstånd för andra. Kunskap kring den egna kroppen 
underlättade också initierandet av sexuella aktiviteter. Upprepade underlivsundersökningar 
upplevdes hota informanternas autonomi och beskrevs som traumatiska. Forskning kring CAH, 
och forskningsdeltagande, beskrevs som viktigt för att förbättra framtida vård men mycket 
forskning ansågs inte vara viktig för den individuella patienten. Informanterna identifierade sig 
som kvinnor men beskrev att de inte kände sig tillräckligt kvinnliga. De hade olika syn på 
barnönskan och graviditet samt vilken roll CAH spelade i deras liv och hur detta påverkade 
deras upplevelser och perspektiv. Skam var ett återkommande underliggande tema och 
understöddes av utsatthet i relation till sjukvårdspersonal, föräldrars skam över sjukdomen och 
återkommande utvärderingar och fokus på normalitet. Sammanfattningsvis så beskrev alla 
informanter att de kämpade för att bli sedda som individer. Målet för studie III och IV var att 
öka kunskapen kring psykiatriska tillstånd bland kvinnor med DSD. Studie III var en 
registerstudie där CAH-registret länkades med patientregister och visade ökad risk för 
psykiatrisk sjuklighet i allmänhet och beroendesjukdomar i synnerhet hos kvinnor med CAH. 
Den sista studien (IV) visade att kvinnor med CAIS och kvinnor med GD har större risk för 
psykiatrisk sjukdom i jämförelse med kvinnor med POI och friska kvinnor i befolkningen. Den 
ökade risken för psykiatrisk sjuklighet bör föranleda ökad uppmärksamhet på psykiatriska 
symtom hos kvinnor med DSD. Sammanfattningsvis så är kvinnor med DSD en heterogen 
grupp individer med olika behov och erfarenheter. Genom att vara uppmärksamma på 
psykiatriska symptom, bistå med åldersadekvat information och strategier för att berätta om 
CAH för andra, kan vårdpersonal hjälpa dessa kvinnor att må så bra som möjligt, både fysiskt 
och psykiskt. Avslutningsvis, genom att involvera personer med DSD i vård och forskning kan 
vi kanske förstå variationen i utfall mellan patienter. På sikt kan vi kanske också underlätta för 
de här personerna genom ökad medvetenheten om DSD. 
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LIST OF DEFINITIONS 
Androgens: Any steroid hormone that activates or controls the development and 
maintenance of male sex characteristics, for example testosterone. 
Androgen insensitivity syndrome: Conditions that cause partial or complete inability of 
cells to respond to androgens. 
Chromosomal sex: Most humans are born with 46 chromosomes in 23 pairs. The X and Y-
chromosomes usually determine a person’s biological sex. Most women have 46,XX 
chromosomes and most men have 46,XY chromosomes. Chromosomal sex can also be 
called genetic sex.  
Confidence interval: The probability that a population parameter will fall between two set 
values. 
Congenital adrenal hyperplasia: CAH is an inherited disorder of the steroid synthesis of 
the adrenal glands. 
Disorders of sex development: Congenital conditions where development of 
chromosomal, gonadal or anatomical sex is atypical.  
Gender: Gender is commonly understood as the social construction, typically described in 
terms of masculinity and femininity and that differs across cultures and over time. 
Psychosexual development involves three main components. Gender identity is the feeling 
of being a boy or a girl. Gender role refers to gender-typical behavior such as preferences in 
toys. Sexual orientation refers to the direction of a person’s sexual interest. 
Genotype: The genotype of an organism is the inherited map it carries within its genetic 
code. 
Gonad: The gonads in males are the testes and the gonads in females are the ovaries. 
Gonadal sex: The sex determined by which kind of gonadal tissue is present (ovaries or 
testes).  
Intersex: A term that was used in medical practice for a person born with a DSD, however 
since the 1990s it also carries a political identity. 
Karyotype: The description of sorted chromosomes in an organism visualized during cell 
division. The most common human karyotype is 44 chromosomes plus two specific sex 
chromosomes (46,XX or 46,XY).  
Odds ratio: The ratio of the likelihood of an event occurring in one group compared to the 
likelihood of the event occurring in another group. Odds ratios are used as a measure of the 
association between an exposure and an outcome. 
Phenotype: Defined as an organism's expressed physical traits. 
Premature ovarian insufficiency: Loss of ovarian function before age 40, premature 
menopause. 
Quality of Life: A concept that usually includes multiple dimensions of subjective 
assessments of both positive and negative aspects of life. 
 Sex: Is commonly known as the state of being male or female.  
In this thesis ‘sex’ will be used in relation to somatic and physiological characteristics and 
‘gender' in relation to psychosocial aspects. However, sex will also be used as a term with 
reference to sexual activity. 
Sex hormones: In most genetic females the primary sex hormones are estrogen and 
progesterone produced by the ovaries. In most genetic males the principal sex hormone is 
testosterone produced by the testes.  
Phenotypic sex: Sex determined by the internal and external genitalia and expression of 
secondary sex characteristics e.g., beard and breast.   
Secondary sexual differentiation: Secondary sexual differentiation comprises features that 
appear at puberty in humans and distinguishes the sexes, but are not directly part of the 
reproductive system. Visible sex characteristics include pubic hair, enlarged breasts in 
female and facial hair and darker voice in males.  
Virilization: The induction or development of male-typical secondary sex characteristics in 
a female or a prepubertal male. 
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1 INTRODUCTION 
In 1948 the World Health Organization described health as ”a state of complete physical, 
mental and social well-being and not merely the absence of disease or infirmity” (1). At that 
time many chronic diseases led to an early death and several of the diseases we treat today 
were not diagnosed because they were unknown to the medical community.  
Thus, ageing with chronic illnesses has become more frequent, largerly thanks to the 
introduction of new pharmaceutical preparations and surgical interventions. Because of this, 
new questions arise that need to be addressed in the care of patients.  
The introduction of glucocorticoids in the 1950s constitutes a paradigm shift in the medical 
treatment of many diseases, such as congenital adrenal hyperplasia (CAH). CAH is a 
hereditary disease involving insufficient production of cortisol and aldosterone from the 
adrenal glands and, at the same time, increased production of androgens. Without cortisol, the 
body cannot regulate salt and glucose balance, leading to an early death. However, with 
glucocorticoid treatment, the majority of children with CAH can now reach adulthood. This 
means that there are now grown-up women and men who have lived with this disease for 
more than 60 years.  
In the beginning of the 1950s an American gynecologist John Morris reported on a group of 
80 patients that appeared to be female but did not menstruate, had sparse pubic hair and had 
testes instead of a uterus (2). It would take several years before chromosomes could be 
analyzed and these women turned out to have the XY chromosomes. After an additional 30 
years, it was concluded that this condition was due to dysfunction of the androgen receptor, 
and the Androgen Insensitivity Syndrome (AIS) was given its present name.  
AIS and CAH are included in Disorders of Sex Development (DSD), an umbrella term used 
when a person is born with a condition which in some way, affects the development of sex.  
Given the medical and surgical advances, and the opportunity for accurate diagnosis during 
the last few decades, questions about how to care for patients with DSD in a broader 
perspective needed to be addressed.  Thus, in 2005 a consensus meeting was held in Chicago, 
Illinois, USA. Fifty medical experts and two patient representatives discussed a number of 
aspects of disorders affecting sex development. Among other things, the meeting focused on 
aspects on how to live with chronic conditions in the best possible way, they concluded that: 
“Quality of life encompasses falling in love, dating, attraction, ability to develop intimate 
relationships, sexual functioning, and the opportunity to marry and raise children, regardless 
of biologic indicators of sex” (3).  
In addition, DSD has been surrounded by questions regarding gender, normativity, and social 
norms. Surgical interventions in the childhood years to correct an atypical sex have been 
debated, as well as what role the health care services play in applying social principles to 
disease or gender, by labeling conditions as sick or healthy, and normal or abnormal (4). 
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In the summer of 2009 the subject of DSD was brought into public consciousness when 
Caster Mokgadi Semenya, a then 18-year-old woman from South Africa, won the women's 
800 meters at the 2009 World Championships in Berlin, Germany. Following her victory 
questions were raised about her sex, thereby initiating an international debate on sex, gender, 
and normality (5).  
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2 THESIS AT A GLANCE 
 
Study 
Research 
question 
 
Method 
 
Results 
 
Conclusions 
I How do women 
with CAH 
describe their 
experiences of 
having CAH, and 
the care given?  
 
Thirteen semi-
structured interviews 
with women with 
CAH analyzed by 
inductive content 
analysis.  
Information sharing is 
difficult because of 
lack of CAH-specific 
knowledge. Genital 
examinations can be 
experienced as 
traumatic. Research is 
considered important 
but it reproduce 
normative gender 
roles. Fighting shame 
is a recurrent theme. 
Information disclosure 
can be facilitated by 
increased knowledge. 
Genital examinations 
should be kept to a 
minimum. New 
research perspectives 
are needed.  Shame 
can be counteracted by 
increased support to 
parents and patients. 
II How do women 
with CAH 
describe their 
experiences of 
identity formation, 
sexuality, and 
parenthood? 
  
Thirteen semi-
structured interviews 
with women with 
CAH analyzed by 
inductive content 
analysis. 
Feeling like a woman 
is threatened by 
normative expectations 
of femininity. Intimate 
relationships are 
hindered by sexual 
difficulties, and 
insufficient 
knowledge. Fertility is 
not taken for granted 
and the wish for 
children varies among 
participants. 
Increased sexual 
education for patients 
and raised awareness 
of DSD in society can 
facilitate psychosexual 
adjustment and sexual 
relationships. 
Increased information 
on fertility and at 
transitions, can aid in 
the adjustment and 
support women with 
CAH.  
III What is the 
frequency of 
psychiatric 
disorders in a 
Swedish cohort of 
girls and women 
with CAH 
compared to 
controls? 
By using the Swedish 
registries the risk of 
psychiatric diagnosis 
among 355 women 
with CAH was 
compared to 1:100 
age-matched male and 
female controls.  
Girls and women with 
CAH have a higher 
risk than both male and 
female controls, to 
have received a 
psychiatric diagnosis. 
In particular they have 
a higher risk of alcohol 
misuse disorders.  
Increased attention to 
psychiatric symptoms 
among women with 
CAH is warranted, in 
particular symptoms 
of addiction, 
depression and, 
anxiety. 
IV Is the frequency of 
psychiatric 
disorders in 
women with DSD 
(CAIS and 46,XX 
CGD and 46,XY 
CGD) different 
from women with 
POI and age-
matched controls?  
20 women with CAIS, 
7 women with 46,XX 
CGD, 6 women with 
46,XY CGD, 21 
women with POI and 
61 population-derived 
female controls were 
assessed using MINI+ 
screening for 
psychiatric morbidity 
Women with DSD 
have an increased 
lifetime risk of any 
psychiatric disorder. 
Mood disorders and 
anxiety disorders in 
particular. There were 
no significant 
differences in risk 
between women with 
DSD and women with 
POI.  
Women with different 
DSD have higher risks 
of developing mood 
and anxiety disorders. 
More attention to 
mental health issues in 
women with DSD is 
needed.  
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3 BACKGROUND 
“Disorders of sex development (DSD)” is an umbrella term for conditions in which the 
reproductive organs and genitals do not develop as expected (6). Since these are rare 
conditions, this Background section is aimed at giving a brief overview of sex differentiation 
in humans, and the etiology, symptoms, and treatment of the DSD conditions included in this 
thesis. In addition, this chapter will summarize the hypotheses of hormone-driven sex 
differences, the focus of much of the research on DSD during the last few decades, and it also 
presents a background to the posed research questions in the four consecutive research 
studies.   
3.1 SEX DEVELOPMENT 
In brief, one might say that nature’s recipe is by default, that all human fetuses will be born as 
baby girls if they are not showered with the right hormones at different periods of the 
pregnancy. Before seven weeks of gestation, all fetuses have an identical reproductive 
anatomy. After this, the fetuses with two X chromosomes start to develop ovaries, and a little 
later, those with a Y chromosome start to develop testes (Figure 1). There are several steps 
during gestation and later, after birth, that affects our perception of sex. The binary division 
between male and female might seem clear and easy, but sex is more complex than what it 
looks like on the outside (7). In the following section, the usual sex development is explained 
in more detail. 
 
Figure 1. Simplified sex differentiation in humans. Sex differentiation begins with sex determination, 
depending on the chromosomal sex. Sex determination involves the specification of the gonads into 
testes or ovaries. Sex hormones are needed for development of external genitalia and secondary sex 
characteristics. 
Chromosomal and gonadal sex 
In humans the successful sex-defining strategy is chromosomal because this allows for early 
and exact programmed sex differentiation. Since all fetuses are sexually undifferentiated until 
seven weeks of gestation, the gonads can be either testes or ovaries, and are therefore called 
bipotential (8). The Y-chromosome has the testes determining genes and they determine 
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which developmental path the gonads will follow, the typical male or female path. For 
example, in persons with two X chromosomes and one Y-chromosome (Klinefelter 
syndrome, 47,XXY), the sex is male. In persons with only one X chromosome (Turner 
syndrome 45,X), the sex is female, but the ovaries do not develop normally, for that, two X 
chromosomes are needed (9).  
This bipotential stage of the gonads occurs from week four until week seven of fetal 
development (9). The major genes for testes determination is proposed to be the SRY gene 
(Sex-determining Region of the Y chromosome), together with an autosomal gene, SOX-9 (a 
gene that is not located on a sex chromosome), and a transcription factor SF1 (a protein that 
binds to specific parts of DNA). The formation of the ovaries is also an active gene-directed 
process that involves DAX1, a gene on the X chromosome. DAX1 has been proposed to 
suppress the SF1 gene and to be involved in the initiation of the ovary through WNT-4 
(Figure 2). However, there are persons with no Y chromosome and no SRY gene that 
develops testes, which suggests theories that the X-chromosome has factors that are testis-
suppressive and ovary-supporting, but these factors are yet to be fully understood (9). 
 
Figure 2. Proposed mechanism for sex determination, where SRY blocks the inhibition by DAX1 on 
SF1. Together with SOX-9, SF1 directs the bipotential gonad into a testis. If two copies of DAX 1 are 
present (XX or no Y chromosome), the SF1 will be suppressed. Via WNT-4 DAX1 then stimulates 
development of the ovaries. After inspiration from Gilbert, 2013. 
Phenotypic sex 
During week six, the germ cells (cells that create reproductive cells) will migrate into the 
bipotential gonad. If the fetus is 46,XX, the germ cell will be enclosed in follicles formed by 
theca cells and granulosa cells. Together, these cells will be able to synthesize estrogen, 
which will be secreted by the follicles. Estrogen, first from the mother and then from the 
gonad, enables the development of the Müllerian duct into an uterus, fallopian tubes and the 
cervix, the upper end of the vagina (8), shown in figure 3. In XY fetuses, the germ cells will 
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form sperms, and Sertoli cells will aid proliferation of the gonad towards the testis. Sertoli 
cells nurture sperm, and produce anti-Müllerian duct hormone (AMH) which suppresses the 
formation of female genitals (10). Meanwhile, Leydig cells in the testes produce testosterone, 
and enable the formation of typical internal male genitals from the Wolffian duct (Figure 3). 
Testosterone is also converted to 5α-dihydrotestosterone (DHT) by binding to the androgen 
receptor. DHT is responsible for the development of the genital tubercle (urogenital sinus and 
swellings) into the typical external male genitalia, the penis.  
Figure 3. Proposed formation of the sexual phenotypes in humans. DAX1 and WNT-4 moves the 
bipotential gonad into ovary development, this leads to formation of follicles and production of 
estrogen, which enables the Müllerian duct to differentiate to typical female genitals. The SRY gene 
moves the development towards testis formation via SF1 and SOX-9. The testis produce AMH that 
causes regression of the Müllerian duct, and testosterone that differentiates the Wolffian duct into 
internal male typical genitalia. Testosterone is converted into DHT that drives the development of the 
penis and the prostate gland. After inspiration from Gilbert, 2013. 
The external genitalia look the same until about nine weeks 
of gestation, and are then directed by sex hormones 
(estrogen, testosterone, and DHT) as shown in figure 4. A 
genital tubercle is formed that first develops into a phallus 
which, in females, forms the clitoris, and in males, the 
phallus forms the glans of the penis. The urogenital fold 
forms the shaft of the penis in males, and the inner labia in 
females. The labioscrotal swelling forms the outer labia in 
females, and the scrotum in males (8).  
 
Figure 4. The development of the external genitalia in week 6, 
week 16, and at birth.  
Published with the kind permission of “Föräldrainformation om 
DSD”, Karolinska University Hospital. 
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3.2  DISORDERS OF SEX DEVELOPMENT 
Even though the differentiation into typical male and female sex most often follows the same 
paths, sometimes the development of chromosomal, gonadal, or phenotypic sex is different 
(3). These differences in development result in several conditions that are included under the 
umbrella term: Disorders, or differences, of sex development (DSD). DSD refers to a 
heterogeneous group of conditions with a range of symptoms and physical differences from 
being born with one extra chromosome, 47,XXY (Klinefelter syndrome), no development or 
underdevelopment of gonads (gonadal dysgenesis), or unclear sex at birth (e.g.,  46,XX 
CAH). Individuals included in the DSD classification have different medical problems and 
needs due to distinct underlying causes, but many share the same difficulties concerning 
social, emotional, and psychical sequelae when growing up (11). In addition, some persons 
with a DSD share hormonal imbalances with known long-term effects and a need for 
multidisciplinary lifelong care (12). The DSD classification is based on subcategorization 
according to sex chromosomes (13), namely, sex chromosome DSD, DSD 46,XY, and DSD 
46,XX, shown in Table 1.  
Table 1. Classification of disorders of sex development based on sex chromosomes,  sex 
chromosomes being the starting point for medical investigations.  
The DSD conditions investigated in this thesis are written in bold..   
SEX CHROMOSOME DSD DSD 46,XY  DSD 46,XX 
45,X  
For example:  
Turner Syndrome.  
Disorders of testicular 
development 
For example:  
Complete gonadal dysgenesis 
(Swyer syndrome) 
Disorders of ovarian 
development 
For example:  
Gonadal dysgenesis 
47,XXY 
For example:  
Klinefelter Syndrome 
Disorders of androgen synthesis 
or action: 
For example, defects in 
androgen action:  
Complete androgen 
insensitivity syndrome  
Disorders of androgen excess: 
For example:  
Congenital adrenal 
hyperplasia 
45,X/46XY 
For example:  
Mixed gonadal dysgenesis 
Other: 
For example:  
Severe hypospadias 
Other: 
For example: 
Vaginal atresia 
46,XX/46,XY 
For example:  
Ovotesticular DSD 
  
The overall incidence of DSD has been estimated to be 1,7%, however, this includes all 
conditions independently of whether they present with ambiguous genitalia or not (3,14–16). 
In Sweden, one in 5000 children (15-20 children each year) is born with a genital anomaly 
that results in unclear sex at birth. Hypospadia is more common, affecting 1 in 125 boys, 
which is an increase from 1 in 223 in the 1990s (17). The most common condition involving 
a DSD in girls is congenital adrenal hyperplasia (CAH), which affects one child in 10,000-
20,000 live births (18). 
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Congenital adrenal hyperplasia 
Congenital adrenal hyperplasia (CAH) is an autosomal recessive condition: this means that, 
in order for the condition to appear, a mutated gene from the mother and a mutated gene from 
the father must be inherited (19). One person out of 50 in the general population is a carrier of 
a mutated gene and one out of 70 are carriers of more severe mutations (20). In 95% of cases 
of CAH, the condition is caused by a mutation in the CYP21A2 gene that provides 
instructions for production of the enzyme 21-hydroxylase (21-OH) which, is involved in the 
synthesis of cortisol, mineralocorticoids (e.g., aldosterone), and androgens (18).  
Cortisol, together with aldosterone, is vital for maintaining electrolyte and fluid balance in 
the body, managing stress response, and mobilizing energy (21). The secretion of cortisol is 
controlled by the stress hormone system in the body, also known as the hypothalamic-
pituitary-adrenal (HPA) axis. The hypothalamus produces corticotrophin-releasing hormone 
(CRH), which stimulates both the synthesis and secretion of adrenocorticotrophic hormone 
(ACTH) in the anterior pituitary, as a response to physical stress (e.g.,  fever, exercise) and 
emotional stress (e.g.,  stressful experiences). In healthy individuals, ACTH is secreted in a 
circadian rhythm, and follows the blood stream to the adrenal glands, just above the kidneys, 
where it causes secretion of cortisol and aldosterone, as shown in Figure 5. Cortisol is highest 
in the morning, and lowest overnight since cortisol, for example, mobilizes energy sources 
to help us through the day. In stressful situations, cortisol levels will decrease, thereby 
sending messages to the hypothalamus, through an intricate feedback, to increase 
production of ACTH.  
 
Figure 5. The secretion of cortisol is controlled by the stress hormone system in the body (the HPA 
axis). In healthy individuals ACTH is secreted in a circadian rhythm.  
The 21-OH mutation in CAH interrupts the biosynthesis of cortisol, resulting in low levels of 
cortisol (19). Because of the intrinsic feedback system, production of ACTH will then 
increase and this will lead to increased synthesis of steroid precursors before the enzyme 
block in the adrenal glands. In lack of the 21-OH enzyme, the precursors will be converted 
Other parts of 
the body Adrenal glands 
Anterior 
pituitary Hypothalamus 
CRH ACTH 
Cortisol 
Promote breakdown of fat 
Glucose production in liver 
Counteracts insulin 
Reduces bone formation 
Aldosterone 
Regulation of blood 
pressure 
Regulates blood levels of 
electrolytes 
Androgens Masculinizing effects 
STRESS 
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into androgens instead of cortisol, as shown in Figure 6. During pregnancy, the affected fetus 
will produce excess androgens, but will be provided with maternal cortisol. 
Figure 6. A defect in the CYP21A gene will affect the development of 21-OH enzyme in the adrenal 
glands. This will lead to production of excess androgens in the adrenal glands.  
Persons with CAH are often classified into genotype groups according to the severity of the 
milder of their two variants of the gene (alleles) since this determines the phenotypic severity, 
with few exceptions. When children are born with the most severe mutation, they will 
spontaneously develop a hypotensive salt crisis in the neonatal period (the first months after 
birth), which untreated, will lead to death. This type of CAH is referred to as “salt wasting” 
CAH (SW-CAH), and is associated with the null mutation, or the I2splice mutation (22). 
Children who do not spontaneously present with salt crisis in the neonatal period, but have a 
cortisol deficiency, and overproduction of androgens, are classified as ”simple virilizers” 
(SV-CAH). SV-CAH is correlated with a I172N mutation. The SW and SV forms of CAH 
are called classic CAH, and have their onset before five years of age.  
Persons with non-classic CAH (NC-CAH) have sufficient cortisol levels, but excessive 
production of precursors due to a partial enzymatic block that results in increased androgen 
levels. The NC-CAH is usually due to V281L and P453S mutations. Despite a vast clinical 
difference between SW-CAH and NC-CAH, there is, in reality, a continuum based on the 
severity of the underlying mutation (23), as shown in Figure 7 . 
 
Figure 7. A continuum of disease severity (clinical phenotype) based on the underlying mutation 
(genotype). The clinical phenotype is based on the mildest mutation in the affected CYP21A2 gene.  
Congenital 
adrenal 
hyperplasia 
21-OH-
Enzyme is 
not working 
Decreased 
amount of 
cortisol and 
aldestorone.   
Increased 
amount of 
androgens 
Multiple 
health 
problems.  
Virilization of 
genitals in 
girls. Early 
puberty. 
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To prevent neonatal death from salt crisis, CAH was included in the Swedish newborn 
screening program in 1986 (24). As the aim of the neonatal screening program is to detect 
severe forms of CAH that can cause salt crisis, milder forms of the disorder are not detected. 
Therefore, some children with non-classic CAH are diagnosed later in life, because of e.g., 
early pseudo puberty due to high androgen levels (19): for example, an increased growth rate, 
or teenage girls who present with increased body and facial hair (hirsutism), or menstrual 
disturbances.  
In classic CAH, replacement therapy with glucocorticoid and mineralocorticoid, as well as 
sodium, is administered to adjust the fluid and electrolyte balance. This will also reduce 
ACTH production, and consequently the excess androgen production (19). Treatment is life-
long and needs to be monitored since the need for cortisol varies over the day, and increases 
with stress, and infections. Classic CAH is the most common cause of unknown sex at birth 
in 46,XX individuals (19). The increased prenatal androgen levels result in varying degrees 
of virilization of the external genitalia, in newborn baby girls (Figure 8). CAH in girls and 
women is therefore characterized as a 46,XX DSD, as described in Table 1. Boys with CAH 
are not virilized, but they also have a life-threatening chronic condition.  
 
Figure 8. Development of external genitalia depending on androgen levels. Increasing levels results 
in virilization of the genitals, independently of sex chromosomes. Graphics: Johan Andersson, DN. 
Published with kind permission from Dagens Nyheter. 
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In the past, genital reconstruction for girls with virilized genitalia was usually performed 
early after birth (25), since the prevailing notion was that psychosexual development was 
dependent on the genitals looking like they were in conformity with the assigned gender 
(26,27). However in 1997, evidence was presented that overturned this type of management 
(28). Nowadays, psychosexual development is known not to be dependent on genital 
appearance, however, functional and reconstructive genital surgery is still being performed, 
but is debated mostly regarding timing, and to what extent the reconstruction should be 
performed (29). The strongest argument for postponing surgery after the neonatal period, is to 
wait until the child can express his or her own preferences and, preferably, can give his och 
her informed consent; however, in any case, the child’s well-being should always be 
prioritized (30).  
Gender assignment in persons with CAH, and 46,XX karyotypes, are predominantly female 
since they have female internal genitalia, and can reproduce. Rearing of male gender in 
46,XX individuals is very rare, but there are cases where the degree of virilization is very 
severe and the parents are reluctant to raise their child as a female (31). Male rearing of 
persons with 46,XX CAH might be more common in countries where there is a lack of new-
born screening programs, and where the genital virilization is not directly understood to be 
because of CAH, and in addition, the prevailing culture has a preference for male gender 
(32). A review of a case series of 46,XX individuals with CAH reared as males showed that 
they have a relatively good psychosocial situation (33). 
During childhood the focus of treatment is optimization of growth, and pubertal progression 
and, in adults, the focus shifts to quality of life and long-term health (34). Despite medical 
advances, and more adequate treatment, short stature remains a problem for many persons 
with CAH, as well as the development of overweight, which can be a consequence of 
overtreatment with glucocorticoids (35). There are also reports on an increased risk of the 
metabolic syndrome and cardiovascular disease (36). The level of compliance may shift 
during different periods of life (e.g., the teenage years), with the result of raised androgen 
levels. This can lead to reversible androgenic effects, such as hirsutism, and irreversible 
effects, such as a deeper voice, because of enlargement of the laryngeal prominence, the 
Adam’s apple (37,38). 
Women with classic CAH have children to a lesser extent than their healthy peers (39). 
However, the causes of the low fertility are unclear, but they have been explained in terms of 
insufficient hormonal control, leading to secondary polycystic ovaries and high progesterone 
levels. Same-sex relationships, and unsatisfactory surgical outcomes, have also been 
proposed as plausible causes (40). On the other hand, there are reports that only 25% of 
women with CAH attempt to get pregnant, and that they have less of a wish for children of 
their own (34,41). Among women with CAH who get pregnant the fecundity rates, i.e., the 
possibility to reproduce, are normal with proper treatment (34,42). 
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Androgen insensitivity syndrome 
As mentioned before, androgen stimulates development, and maintains typical male sex 
characteristics, by binding to the androgen receptor (AR). Therefore, a dysfunction in the 
androgen receptor, as in androgen insensitivity syndrome (AIS), will lead to no development 
or underdevelopment of typical male genitals, and sex characteristics (43), as shown in 
Figure 8. The clinical presentation depend on the severity of the dysfunction of the AR, 
resulting in different degrees of insensitivity to androgens resulting in a continuum of 
phenotypes (44). Besides complete AIS (CAIS), there are also partial androgen insensitivity 
(PAIS), and a mild form (MAIS). AIS is an X-bound condition, which means that 
individuals with an XX karyotype are usually only carriers, because the X with mutation will 
be inactivated. Thus, only XY individuals are born with AIS. The estimated incidence of AIS 
ranges from 1 to 5 in 100,000 live births (45). 
In CAIS, a baby with a chromosomal sex of 46,XY, and a severe dysfunction of the androgen 
receptor, will present with a female phenotype (Figure 9). However, the baby will have age-
appropriate testicular androgen levels, but they cannot bind to the AR. There is a lack of sex-
determining genes for the female pathway will result in a shallow vagina without a uterus 
(46). This is because the testes are functioning, and produce AMH, which leads to normal 
regression of the Müllerian ducts, that otherwise would have formed the uterus.  
 
 
Figure 9. In CAIS the chromosomal sex is XY, and testes determining genes are present, thus 
internal male genitals will develop. However, a dysfunction in the androgen receptor will lead to no 
action of circulating androgens, and the phenotype will therefore be female.  
In the case of CAIS, the majority of patients identify as females (47). The girls with CAIS 
usually presents with primary amenorrhea in adolescence; however, a suspicion can be raised 
sometimes if a baby girl presents with inguinal hernia where testes are found (48). If there is 
a family history (X-linked recessive), or with new forms prenatal testing, such as noninvasive 
prenatal testing (NIPT), a mismatch can be found between a fetal 46,XY karyotype, and a 
baby girl being born. 
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In women with gonads, there will be plentiful androgens circulating in the body. Androgens 
will, through an aromatization (a chemical reaction) form estrogens, which will lead to a 
typical female phenotypic pubertal development with breast and female adiposity. Since there 
is no androgenic action, these women will have none, or sparse pubic and axillary hair. 
Women with CAIS will also be taller than the average woman, but not as tall as the average 
man (46). In general, the vagina is underdeveloped (hypoplastic) and the first line treatment 
option is self-dilatation therapy and second-line treatment is surgery (vaginoplasty) (49). 
Since women with CAIS have no uterus, and thus no menstruation, there is no possibility of 
conceiving, or bearing children.  
There is a tumor risk in gonads that have not developed as expected, however, the general 
recommendation in CAIS is to perform biopsies of the gonads after puberty, and then do 
regular clinical controls, if the biopsy specimens show no sign of malignancy (50). The 
treatment is then substitution with estrogens, e.g., combined oral contraceptive pills (51). 
Hormonal supplementation is also important for bone health and prevention of osteoporosis. 
Some women with CAIS prefer treatment with supplementary testosterone after 
gonadectomy because this improves their well-being (51). 
Gonadal dysgenesis 
In CAH there is an excess of androgens from the adrenals causing a virilization, and in CAIS 
there is a dysfunction of the androgen receptor, that results in a lack of androgen action. In 
gonadal dysgenesis (GD), the ovaries or testes do not develop as expected, resulting in lack 
of estrogens and androgens (52,53). 
Ovarian dysgenesis results from genetic defects in ovarian development in the bipotential 
gonad, or later in sex differentiation. The exact underlying cause is unknown in most cases, 
and several genes, including DAX-1 and SF-1, as well as SRY, have been implicated in the 
causation of the defects (54,55). In persons with 46,XX CGD, hormone stimulation from the 
gonads is totally absent and, instead of ovaries, they have undeveloped lumps of tissue called 
streak gonads. However, they present with a typical female phenotype, and develop a uterus 
(Figure 10). This is also the case in persons with 46,XY CGD, also known as Swyer 
syndrome (52). In 46,XY CGD, a uterus is formed together with Fallopian tubes, because the 
testes are non-functional, and does not produce testosterone, or anti-Müllerian hormones. The 
underlying cause of the Swyer syndrome has not been fully established; however, in 
approximately 15% of cases there is a mutation in the SRY gene (52). It is also known that 
two X chromosomes are needed for fully develop ovaries (9).  
Persons with CGD are typically raised as girls and have a female gender identity. Swyer 
syndrome occurs in approximately 1 in 80,000 persons (56). The prevalence for 46,XX CGD 
is unknown, but it is thought to be less than 1 in 10,000 live births (57). 
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Figure 10. Genetic defects of ovarian or testicular development, or other causes of non-development, 
will result in absence of hormone production (estrogens or androgens) and the phenotype will be 
female.  
Medical management includes hormone replacement therapy, and protection of bone health 
with supplements of calcium, and vitamin D (51,58). As in the case of CAIS, there is an 
increased risk of gonadal tumors in women with 46,XY CGD (54). Thus, surgical removal of 
gonads are recommended (50,53). Since women with CGD do not have oocytes (because 
they have no ovaries), or hormone production, no fertility is expected. However, pregnancy 
may be feasible through zygote donation, i.e., a fusion between an egg and sperm (51,59). 
3.3 HORMONE-DRIVEN SEX DIFFERENCES  
Given that different DSD result from chromosomal, gonadal, or hormonal differences during 
development, DSD has served as an ”experiment of nature” for elucidating sex hormones’ 
effect on gender development, gender behavior, and sexual orientation (12). The two 
following sections of this background will therefore address the theories pertaining to 
hormone-driven sex differences in behavior, in relation to persons with DSD. 
It all started in 1959, when a paper was published on sexual behavior in male and female 
guinea pigs, whose mothers had received synthetic testosterone during most of the 
pregnancy. In addition, after birth the guinea pigs received high doses of testosterone until 
adulthood (60). The experiment showed that high doses of testosterone changed external 
genitalia in newborn female guinea pigs, to external genitalia identical to those of newborn 
male guinea pigs. The adult female guinea pigs also showed a mating behavior that differed 
from unaffected females, and were more like adult male guinea pigs, suggesting that 
androgens administered during pregnancy (prenatally), had an organizing effect on the 
brain, and an activating effect on the brain in adulthood, leading to more male-like mating 
behavior (60). The paper was first considered to be radical, but the hypothesis first posed by 
the authors is now referred to as the “organizational hypothesis”, and it is the predominant 
explanation for the origin of sex differences in behavior (61).  
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Much research has followed in the footsteps of this first article, and several studies on non-
human mammals have repeatedly shown results in line with those of Phoenix and his 
colleagues (62,63). Today, with the increased level of knowledge that is available, the 
organizational theory can be summarized as the notion that the nervous system differs 
between males and females, and that, during sensitive periods hormones produce permanent 
changes in brain structures, as well as the rest of the body, thereby generating masculine or 
feminine behavior (61,64,65). 
Behavioral sex differences between humans are, for example, gender identity and sexual 
orientation, with more than 90% of adults reporting sexual attraction to persons of the 
opposite sex (64). Other differences include childhood play and personality traits, such as 
aggression and empathy. In addition, behavioral sex differences in the brain have also been 
suggested to be involved in psychiatric disorders. For example, the extreme male brain theory 
of autism suggests that prenatal androgens contribute to such autistic traits as impairment in 
empathy and an extreme drive to systemize (66). Differences are of course, measured on a 
group level and cannot be applied to a specific individual. In addition, gender differences are 
also dependent on other things, such as cultural expectations, and cannot be explained solely 
by hormones. 
Women with DSD and the organizational hypothesis 
In 1968, Ehrhardt, Epstein, and Money noted that girls with CAH had a more boy-like 
behavior than girls without CAH (67). Since then, much of the focus on the management of 
children with a DSD has been on gender identity, gender role behavior, and sexual 
orientation (68).  
In several research studies, girls and women with CAH, show an increase in masculinized 
behavior, such as gender-typical toy preferences (69–71), and more interest in male-typical 
activities, than unaffected girls and women (71,72). In addition, they also show increased 
rates of same-sex attraction compared to unaffected women (65,73,74). The Swedish group 
was able to show that gender-atypical behavior in girls with CAH is correlated with the 
severity of the CYP21A2 mutation, suggesting that prenatal androgens have dose-dependent 
effects on the development of gender-specific brain functions (69,75). To summarize, 
prenatal exposure to higher levels of androgen is correlated with more male-typical 
behavior (64).  The majority of women with CAH who are reared as female, have a female 
gender identity, suggesting that prenatal androgens do not alter gender identity (76). 
Nonetheless, there are higher rates of gender dysphoria among women with CAH compared 
to population controls, as well as not feeling content, or satisfied with female gender (74,77–
79).  
The organizational hypothesis has also been applied to women with an XY karyotype (e.g., 
CAIS) who, unlike women with CAH, are suggested to have insufficient levels of active 
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androgens. The strength of CAIS as a model disorder for studying the effect of androgens on 
gender development is the separation of prenatal androgens and sex chromosomes (80). 
Studies have shown significantly more feminine gender-related behaviors in girls with CAIS 
than in children with PAIS and unaffected children (81). In addition, several studies on 
women with CAIS show that they have a female gender identity from childhood, that 
persists through adulthood, and almost always, a sexual orientation toward the opposite sex 
(47,82–84). This implies that the Y chromosome may be unrelated to sexual orientation and 
gender identity.  
There are, of course, alternative explanations concerning the hypothesis of prenatal androgen 
excess, such as the indirect effect of masculinized genitalia on psychosexual development 
(85). In addition, it is still unclear as to what extent biological factors, such as genes or sex 
hormones, or psychosocial factors, such as parental attitude, or the cultural context, influence 
gender identity development, and the stability of that identity. 
3.4 PSYCHIATRIC AND PSYCHOLOGICAL ASPECTS 
The focus on androgen effects has influenced research in CAH. A review of psychological 
outcome studies on CAH presented in 2010, showed that the majority, 68% of studies, 
investigated endpoints related to psychosexual development, and even more studies (76%) 
examined whether psychological outcomes were associated with prenatal androgen exposure 
(76). The evaluation of clinical management has also been heavily focused on gender 
assignment outcomes, and the timing and need of surgery (86–89).  
As mentioned before, in the 1950s, the standard care given, including reconstructive genital 
surgery, emerged from the prevailing notion that if a child’s body was gender-typical, it 
would make the child’s adjustment easier (27). It was also advocated that withholding 
information could help the child not to question the gender of rearing (4). However, in 1997 
evidence was reported that gender identity was not dependent on gender-congruent bodies 
(28). In the 1990s, criticisms of various aspects of clinical practice related to DSD were 
raised by affected adults who were not satisfied with their treatment, or the focus on gender: 
“Intersexuality is primarily a problem of stigma and trauma, not gender” (90). The 
criticism also included assertions that psychosocial problems could not be handled medically 
or surgically (4). Voices were raised questioning what “normalizing” surgery is, to what 
extent genitals are considered abnormal, or untypical of a certain sex and if a DSD is a 
disease or if the individual just fails to fit the definition of normality (4). Furthermore, the 
term “disorders of sex development”, has been debated, and patient advocacy groups argue 
that a disorder is something that needs to be corrected (91).  
According to the Consensus Statement on Management of Intersex Disorders from 2005 (3), 
evaluation of long-term outcomes in DSD should consider the phenotype of the internal and 
external genitalia, somatic health, fertility, sexual function and psychosexual adjustment, 
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mental health, quality of life, and social adjustment and participation. Multidisciplinary teams 
including a mental health professional were recommended to take care of persons with a 
DSD, at the time of diagnosis, and during their lives, in order to improve the education of the 
affected persons and their parents on their specific DSD (11).  
Parents 
Since many individuals with a DSD are diagnosed at an early age, decisions pertaining to 
surgery and treatment are handled by treating clinicians and parents until the child can give 
his or her own informed consent to such interventions as reconstructive genital surgery (3). 
Evidently, most parents will find it highly traumatic if their child is born with unknown sex, 
and parents to children with a DSD have showed high rates of posttraumatic stress (92). Even 
after the diagnosis is made, the parents will have to handle both treatment, decision-making 
regarding surgery (together with a multidisciplinary team) and cope with uncertainties about 
the child’s development. Parents show the highest levels of stress when thinking about past, 
or future events, regarding their child’s condition, but, regarding gender expression, they 
have low levels of stress (93). The parents’ ability to cope with the condition, may affect the 
child (11). A Brazilian study showed that parents’ main concerns were related to having a 
child with unclear sex at birth, was that physicians did not talk openly with them about their 
child’s condition. This led parents not to inform their children, and subsequently, to patients 
protecting their parents from additional suffering by also withholding information (94). Good 
communication between parents and caregivers is looked upon as being extremely important 
and can decrease stress and improve outcomes for children with a DSD (95).  
Psychosocial adjustment 
For a long time, it was common praxis that physicians and parents withheld information 
about a DSD diagnosis, or sex characteristics (e.g., XY chromosomes in a girl) because it was 
believed that this could make the patient confused or upset. However, this has been shown to 
do more harm than good, because the individuals’ limited knowledge about their bodies leads 
to a lack of compliance with treatment, and contributes to silence and shame (96). Women 
with CAH have described their experiences of information sharing as resulting in a sense of 
isolation and embarrassment (97). Although the consensus statements on the management of 
DSD assert that all medical information should be age-appropriate when shared with the 
person affected (3,98), information management has still proven to be difficult, both between 
persons with a DSD, and parents, and caregivers, as well as between persons with a DSD, 
and their peers (99,100).  
Adult persons with CAIS also show major distress related to questions of infertility, identity, 
secrecy, stigma, and shame (101). However, there were no significant differences regarding 
psychological wellbeing in adult women with CAIS, compared to data on norms (82). A 
long-term medical follow-up of women with CAIS, concluded that they did not differ in 
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medical, surgical, and psychosocial outcomes, although 80% had had psychological 
counseling (47). The presence of a psychologist in the outpatient routine has shown to be 
particularly important for the medical consultation (94). 
Two studies found no significant differences between adult women with CAH and controls 
regarding psychological wellbeing (102,103). However, Swedish registry research shows that 
women with CAH have increased rates of disability pensions and sick leave compared to sex- 
and age-matched controls (39). They were also less often married, and had fewer children. 
However, epidemiological studies cannot answer the question of “Why”, which prompts 
further studies using other methods. 
Quality of life (QoL) is the general well-being of individuals, including both positive, and 
negative parts of life. The health related quality of life (HRQoL) also encompasses such 
health related issues as lack of energy. Measurements of QoL and HRQoL are used in 
persons with DSD to determine the impact of medical interventions on psychosocial well-
being, and adjustment. Now, specific QoL instruments for children with DSD and their 
parents are under development, and preliminary results show the need for increased 
psychosocial support (93). However, specific QoL measurements for adult persons with a 
DSD are lacking (76). Previous studies have shown both compromised and equal, as well as 
better, QoL for women with CAH than for a reference group (75,89,102,104). Persons with 
46,XX and 46,XY DSD have been reported to have a good QoL (105,106), but late treatment 
impaired the QoL (106). Persons with CAH seem to have a QoL equal to that of persons with 
CAIS and GD (107,108). To summarize, the results are inconsistent and it is not fully 
understood what predicts QoL among adult women with DSD.  
Psychosexual adjustment 
The consensus statement on the management of DSD (3), asserts that the focus should not be 
solely on sexual function and activity, but also on interpersonal relationships. Studies looking 
at psychosexual endpoints have been criticized for drawing too far-reaching conclusions 
about DSD as the sole factor or the mediator for impaired psychosexual adjustment, and for 
neglecting alternative conclusions, such as living with a chronic illness, or such psychological 
factors as just knowing that you could have sexual difficulties because of early surgery or a 
notion that you deviate from the norm (76,109). 
It has been reported previously that women with CAH have varying experiences of the 
perception of their gender roles and gender identity (97). Furthermore, in women with CAH, 
reduced genital sensitivity, impaired body image, as well as lack of female identification, 
have been suggested to be reasons for psychosexual impairment, and difficulties in relating to 
a sexual partner (102,110). Compared to age-matched women with diabetes, women with 
CAH were less sexually experienced in all areas and reported higher levels of problems with 
lubrication, pain, and penetration (111). In addition, there are difficulties in dealing with 
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questions involving sexuality among persons with CAH (112). In contrast, when in a 
relationship, women with CAH seem to have more stable and satisfying partnerships than 
healthy controls (110).  
A small study investigating adult women with CAIS (n=12), concluded that they seem to 
have stable gender identity throughout their lives (84). However, it has been reported that 
women with CAIS who know about their XY karyotype, can start questioning their gender 
identity, and that this affects their self-esteem, and results in a lack of sexual confidence and 
sexual satisfaction (113). There are also reports on women with XY chromosomes who are 
not content with a female identity, because of the lack of menstruation and infertility (101). 
As well as fear of ”devaluation”, because they do not feel like ”normal” women, and deviate 
from the norm (96,109). The sexual impairments reported in a study of older women with 
CAIS (median age 45), were found to not be due to CAIS per se, but to obesity or 
experiences of previous sexual violence (47). In addition, some studies show an overall 
satisfaction with sexual development and sex life, among women with XY chromosomes 
(47,82,114).  
Mental health 
Studies on long-term mental health outcome in women with DSD are scarce and there are 
such limitations as small sample sizes, a lack of control groups or use of standardized 
measures. However, the consensus statement calls for a multidisciplinary team that includes 
mental health providers specialized in DSD (6).  
The results of studies evaluating mental health among persons with DSD are contradictory, 
e.g., not showing a higher prevalence of psychiatric disorders (103), or significant 
psychopathology in several studies (115–117). On the other hand, results for children and 
adolescents with CAH show increased rates of psychiatric manifestations (79,118,119). Adult 
women with SW-CAH have been found to have increased rates of depression, anxiety, and 
substance misuse, compared to controls (120). In line with these circumstances, persons with 
CAH report high rates of distress, with the highest rates occurring among persons with SW-
CAH (121). A Swedish epidemiological study on men with CAH (n = 253) showed increased 
rates of psychiatric disorders, particularly suicides, attempted suicides, and substance misuse 
(122). In persons with XY DSD increased rates of distress have been reported (105), as well 
as critical levels of depression (113), suicidal thoughts, and previous suicide attempts 
(101,121). Persons with a XY DSD also report concerns regarding poor surgical outcome, 
and distressful memories (108).  
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3.5 RATIONALE FOR THIS THESIS 
During the last decade, the field of DSD research has been dominated by the sequencing of 
new genes in order to understand the genetic causes of DSD and studies elucidating the 
organizational hypothesis regarding women exposed to an excess or lack of androgens. 
However, what the factors are that may account for the variability of outcomes in women 
with DSD is still unclear. Moreover, there have been few studies about how women with a 
DSD cope with their condition or experience the care that they have received.  
Furthermore, previous research evaluating mental health in cases of DSD has shown 
increased self-rated mental symptoms, which warrants the use of structured clinical 
interviews and large cohorts. This may ascertain whether or not DSD diagnoses are linked to 
common psychiatric morbidities, such as depression or anxiety. It is challenging, however, to 
perform large studies on such rare conditions as DSD and, therefore, studies evaluating 
mental health among persons with DSD are scarce. Sweden provides unique investigational 
possibilities since all Swedish residents have a unique personal identification number that can 
be linked to nationwide registries. Thus, the Swedish registries can provide data enabling 
total population studies.  
Some diagnoses included in the umbrella term DSD might force individuals to have life-long 
medical treatment, e.g., because of a deficiency of stress hormones, leading to situations were 
simple infections can be life-threatening. In addition, women with DSD also have to handle 
lifestyle and intellectual challenges, and they also have to process the emotional 
consequences of a chronic condition. They may also have the added burden of being born 
with XY chromosomes, or differently developed external genitalia. In addition to this, not 
much is known about how women with DSD understand the elusive research on androgens’ 
effect on behavior.  
Increased knowledge about psychological and psychiatric aspects can help in the 
improvement of caretaking and mental health outcomes. In particular, patient perspectives 
can reduce the knowledge gap comprising the discrepancies between clinical outcomes, 
research results, and the patients’ experiences. In addition, the perspective of the patients is 
vital in patient-centered care since their experiences may enable new solutions to problems, 
and to improving management in health care. 
Taken together, the findings in this thesis may deepen our understanding of personal 
experiences of living with a DSD, and the mental health status of individuals with DSD with 
the potential goal of both improved caretaking and improved well-being of individuals with 
DSD. 
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4 AIM 
The overarching aim of this thesis was to investigate psychological and psychiatric aspects in 
women with disorders of sex development.  
The specific objectives, and research questions addressing the overarching aim were: 
• To explore women’s personal experiences of living with CAH.  
i. How do women with CAH describe their experiences of having CAH, and the 
care given? (Study I) 
 
ii. How do women with CAH describe their experiences of identity formation, 
sexuality, and parenthood? (Study II) 
• To increase the knowledge of psychiatric disorders among women with DSD. 
i. What is the frequency of psychiatric disorders in a Swedish cohort of girls and 
women with CAH, compared to matched controls? (Study III) 
 
ii. Is the frequency of psychiatric disorders in women with DSD (CAIS and 46,XX 
CGD and 46,XY CGD) different from that of women with POI, and age matched 
controls? (Study IV) 
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5 METHODS 
The choice of method should be guided by the scientific problem and the particular research 
question, and the method should enable the researchers to collect the data that is needed to 
answer the research question (123). However, there is always a question of such practical 
issues as knowledge of the subject under study, available data, and time, which, over the 
trajectory of the research project, will influence decisions and choices of paths.  
5.1 METHODOLOGICAL ASSUMPTIONS 
When conducting research, the researcher always has his or her own research approach, a 
paradigm that affects perceptions, beliefs, and understanding of the research (124). A 
paradigm can be understood as being the lens we use to look through, when we observe what 
is around us. In addition, a paradigm can also be understood as an aid to deciding what 
questions are asked, what answer are given, and how the research experiments should be 
performed (125).    
Quantitative health research is often positioned in a post-positivistic tradition, searching for 
an objective truth, but taking potential confounders and biases are taken into account. Thus, 
the post-positivistic research paradigm assumes that it is possible to approximate, but never 
fully know the truth (124,126). In contrast, many social scientists have an interpretative 
approach in research that does not strive towards a single truth, but rather implies that 
humans make sense of their world, and give it meaning. The interpretative approach seeks to 
understand the individual’s everyday experience (127). Moreover, with a pragmatic 
approach, quantitative and qualitative approaches can be seen as different methods of 
research, to be used in relation to the particular research question (128). The research 
approach guides and frames which question should be asked (e.g., why, how many), and 
what methods should be used to answer it (e.g., interview studies, surveys).  
Given my background as a medical doctor, I had a post-positivist approach at the beginning 
of this project. However, after starting to understand qualitative methods and employing 
approaches to analyzing interview data, I realized that I had adopted more of an interpretive 
approach concerning how to look upon knowledge. Thus, I look at knowledge as something 
that we create through interactions, and that reality is a product of interactions between 
people: for example, between participants and researchers (124). However, since this thesis 
uses both qualitative and quantitative methods, parts of this project are positioned within the 
post-positivistic tradition (Studies III-IV), whereas other parts are conducted with 
interpretative influences (Studies I-II). Therefore, I find myself endorsing a pragmatic stance 
and approach to my research, using the lens most appropriate for the research questions I 
intend to answer. 
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5.2 OVERVIEW OF METHODS  
Given the pragmatic approach taken in this thesis, both qualitative and quantitative research 
strategies were used, guided by the specific research questions shown in table 2. In Studies I 
and II, a qualitative approach was used to answer the research questions concerning how 
women with CAH describe their experiences of living with the condition. In Studies III and 
IV, quantitative methods were used to answer the research questions concerning the 
frequencies of psychiatric morbidity in women with DSD. By linking the Swedish registries 
frequencies of psychiatric disorders in women with CAH were estimated, and structured 
clinical screening instrument were used to evaluate psychiatric disorders in women with 
DSD, and those with POI. The results in Studies I and II answers the questions of “How?” 
and “Why?” and the results in Studies III and IV answer the question of  “How much?”, 
thereby complementing the results of the qualitative studies.  
Table 2. Schematic overview of methods in Studies I-IV   
 Research 
question 
 
Approach  
 
Design 
Study 
population  
Study 
sample  
 
Data 
 
Analysis 
I How do women 
with CAH 
describe their 
experiences of 
having CAH, 
and the care 
given? 
Qualitative   Interview 
study 
Women 
with CAH 
13 
women 
with 
CAH  
In-depth 
semi-
structured 
interviews 
Inductive 
qualitative 
content 
analysis 
II How do women 
with CAH 
describe their 
experiences of 
identity 
formation, 
sexuality, and 
parenthood? 
Qualitative   Interview 
study 
Women 
with CAH 
13 
women 
with 
CAH  
In-depth 
semi-
structured 
interviews 
Inductive 
qualitative 
content 
analysis 
III What is the 
frequency of 
psychiatric 
disorders in a 
Swedish cohort 
of girls and 
women with 
CAH compared 
to controls?  
Quantitative  Matched 
case 
cohort 
study 
Women 
with CAH 
335 
women 
with 
CAH 
Linked 
data from 
Swedish 
registries. 
Conditional 
logistic 
regression. 
IV Is the frequency 
of psychiatric 
disorders in 
women with 
DSD different 
from that of 
women with 
POI and 
controls? 
Quantitative Cross 
sectional 
study 
Women 
with DSD 
and women 
with POI 
32 
women 
with 
DSD 
and 21 
women 
with 
POI 
MINI+ 
screening 
χ2 Test or 
Fisher's 
exact test. 
Logistic 
regression 
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5.3 QUALITATIVE STUDIES 
The following section will address the methods in the first two studies. They were designed 
as interview studies, given that the aim of the studies was to explore women’s personal 
experiences of living with CAH.  
Study population and sample 
Women with CAH were chosen as a study population since previous research prompted 
studies on women’s own experiences of having CAH. As described earlier, much of what is 
known about the psychological aspect of having CAH is derived from research focused on 
demonstrating the influence of androgen exposure in 46,XX individuals (76); thus the 
individual patient perspective is lacking. 
The treating gynecological endocrinologist asked women with CAH if they would like to 
participate in an interview study, as part of a larger follow-up study at Karolinska University 
Hospital in Stockholm, Sweden (129). Women with known intellectual disabilities, women 
who did not speak Swedish, or women younger than 18 years of age were excluded from 
recruitment.  
Purposeful sampling comprises different non-probability sampling techniques, which can 
also be called purposive, judgmental, or selective sampling (130). Since one aim of 
qualitative methods is to collect rich information related to the phenomenon under study, 
purposeful sampling can identify persons who can contribute with rich, phenomenon-specific 
information, and thus ‘information power’ (131). Consequently, purposeful sampling 
increases the probability of the participants providing rich and varied information (130). 
Moreover, a prerequisite for participation in interview studies is willingness to share thoughts 
and experiences (132). 
Guided by purposeful sampling (130), the participants were recruited to achieve richness and 
variation in the data: thus, they varied in age (19-51 years, mean age 33), and had different 
disease severities (SW, SV, and NC CAH), with corresponding genotypes (Null, I2splice, 
I172N and P453). However, during interviews and the analysis, the information regarding 
each participant was blinded to the research group. Eleven of the 13 women had experienced 
genital surgery, and all participants had substitution therapy. All participants identified 
themselves as females. At the time of the interviews, four women had children, and ten had a 
current romantic partner.  
In total, 32 women were asked to participate, 16 declined due to a lack of time, geographical 
limitations, or being tired of research studies. Three persons were never interviewed due to 
time and geographical limitations. The women who did not want to participate were 
comparable to the interviewees concerning children, phenotypes, genotypes, and the number 
of surgeries.  
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Data collection  
The DSD research group in Stockholm has published a substantial number of studies on 
fertility, sexual function, surgical and metabolic outcomes, and gender role behavior. 
However, the impact of CAH on childhood and relationships was not correlated with the 
severity of CAH (75), thus prompting studies on individual experiences of the care given, the 
experience and views of living with CAH, and to what extent this has influenced 
relationships, gender identity, and sexuality.  
The interview guide was developed to cover the areas identified by clinicians and researchers 
at the Karolinska University Hospital and Karolinska Institutet (Table 3). All interviews 
ended with questions regarding “How can we do things differently (regarding care)?” and 
“What can we learn from your experiences?” The interviews were conducted in a semi-
structured way, which means that the interviewer follows the interview guide, but has the 
opportunity to ask individual follow-up questions regarding interesting subjects that might 
arise (133).  
Table 3. Semi-structured interview guide questions for Studies I and II with example supplementary 
questions. 
 Fixed questions  Example supplementary questions 
Having CAH  Could you tell me about your 
condition and your experiences 
of having CAH? 
Your knowledge of your 
condition? 
What are your experiences of 
health care? 
What are your experiences of 
research? 
When did you first learn about your 
condition? 
How, when, and who informed you 
about your condition? 
What are your experiences of treatment 
regimes? 
Why do you agree to participate in 
research studies? 
Gender identity & 
gender behavior 
What were your interest as a 
child? 
What are your interests today? 
Do you have any thoughts about 
gender identity? 
What do you think about the term 
“tomboy”? 
 
How has having CAH affected your 
childhood? 
 
How has CAH affected your teenage 
years? 
Relationships & sex Have you had any romantic 
relationships? 
Have you had any sexual 
experiences? 
Are there any difficulties you would like 
to share? 
Were you worried before hand? 
 
Children & family What are your thoughts about 
having children? 
Do you have children of your own? 
Was it hard to get pregnant? 
For the future What we can learn from your 
experiences? 
What can we, as caregivers, change in 
the future for girls and women with 
CAH? 
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All interviews were individual, face-to-face interviews, and were organized at a time and 
place most convenient for the participant: most participants preferred to be at home and some 
at the hospital. The interviewer (main supervisor) was, at that time, not involved in the care of 
persons with DSD, and had had no prior contact with the participants, thus, she introduced 
herself as a medical doctor with a PhD who had written a thesis about hypospadias. The 
interviews lasted between 60 and 90 minutes and were recorded and transcribed verbatim. 
In the transcripts, such observations as laughter, crying, or sighing, were also noted. In 
total, 424 pages of data were transcribed. 
Data analysis 
The data analysis was performed using inductive content analysis. Given that all interviews 
were completed when the analysis started, the method was well suited to condense extensive 
raw data text, into a shorter comprehensive format (134–136). The primary purpose of using 
an inductive method, was to allow an interpretative approach with subjective interpretations 
of the research findings to emerge from the raw data, and to give rich descriptions of the 
experiences of women with CAH, without a pre-determined theory or pre-existing coding 
framework (135). The analyses for Studies I and II were, however, also inspired by directed 
content analysis sine prior research on the phenomenon guided the research questions, 
comprising deductive assumptions (137). The use of an inductive approach was intended to 
facilitate understanding of complex data, by developing categories from the raw data.  
The stepwise process of qualitative content analysis includes the following steps (135): 1). 
Reading the transcribed interviews several times, 2). Identifying meaning units related to the 
aim of the study, and questions in the study guide, 3). Condensing meaning units and 
assigning codes describing the investigated phenomenon, 4). Group codes into subcategories, 
and categories 5). Analyzing the data on an interpretational (latent) level (Figure 11). 
 
Figure 11. Qualitative content analysis is stepwise process with a back and forth movement between 
emerging categories and the raw data, i.e., the transcribed text from the interviews. The latent theme 
is the interpretation of the underlying meaning of the text.  
Text 
Meaning 
units 
Codes 
Sub- 
categories 
Categories 
Latent 
theme 
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Following these steps, the analysis started with becoming familiar with the text by thoroughly 
re-reading the transcribed interviews, and highlighting important parts of the text that was 
judged to be important, or that corresponded to the research questions, related to the care 
given and having CAH (Study I), or experiences of identity formation, sexuality, and 
parenthood (Study II). The highlighting was done separately by the PhD student and the 
main supervisor and then compared to look for similar or different judgments of what was 
expressed in the text. Data were discussed iteratively during the analysis and the second 
author, an experienced qualitative researcher, supervised the analytical process and facilitated 
research group discussions throughout the analytical process.  
To facilitate the sorting of the data, the free software Open Code was used (138). First, the 
highlighted parts of the text related to Study I (content areas), were analyzed. The 
highlighted text, the meaning units, were imported into Open Code, and then shortened into 
condensed meaning units, shorter segments of text that preserves the core content. The 
condensed meaning units were then assigned codes and then classified and reclassified into 
different mutually exclusive subcategories and then categories. Examples of the manifest 
analysis, including meaning units, condensed meaning units, codes, subcategories, and 
categories are shown in Table 4.  
Table 4. Examples of the analytical process for the manifest content in Studies I and II.  
Meaning unit  
(Participant’s quote) 
Condensed 
meaning unit 
Code Subcategory Category 
There was a lot of “hush hush” 
around it (CAH). Why I was in the 
hospital, well it was made up that 
it was because I had asthma. I 
almost believed I had asthma 
when I grew up because it (CAH) 
was something that you absolutely 
could not talk about. 
“Hush hush” 
around CAH.  
 
It was made up 
that it was because 
I had asthma. 
 
Something you 
absolutely not 
could talk about. 
Information 
from 
parents.  
 
Information 
to peers. 
 
Shameful 
condition. 
 
Parents and 
peers 
 
Information 
(Study I) 
It is important that children who 
are born with my disease will 
have better conditions than I have 
had /…/ in order to develop 
knowledge it is important that I 
am a part of this (study).  
 
Better conditions 
for children.  
 
In order to develop 
knowledge, it is 
important to be 
part of the study. 
Improve 
health care 
 
Important 
to be part 
of research. 
 
Being the 
subject of 
research 
 
Research 
(Study I) 
It is really hard to understand, I 
can imagine, but during my 
childhood, the question if I am a 
boy or a girl, I got it so many 
times. It happens even today, but 
now I don’t care because men 
can’t have children. 
 
Questions if boy 
or girl - I got it so 
many times.  
 
I don’t care 
because men can’t 
have children. 
Questions 
of gender  
 
 
Men can’t 
have 
children 
 
As a girl 
 
 
As a woman 
 
Forming 
identity 
(Study II) 
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The first and the last author then classified and reclassified the codes of the first two 
transcribed interviews until a consensus was reached, and the first author then coded the 
subsequent 11 interviews, using the evolving code manual that was initiated during the first 
two interviews. When all data were coded, the coding consistency was rechecked to see that 
new codes had not emerged or that the understanding of the codes was consistent in all the 
data.  
Subsequently, the codes were sorted into different mutually exclusive subcategories, and the 
emerging subcategories were discussed in the research team, consisting of specialists in 
gynecological endocrinology, pediatric surgery, and psychology, who were well suited to 
judge the credibility of the findings. Comparisons between the subcategories and the original 
parts of the data were made in order to provide trustworthiness, and a broad understanding of 
the data. Subcategories were then sorted in to exclusive categories, and the discussions in the 
research team occurred regularly during the analysis period to avoid analytical 
preconceptions, and to attain a consensus in the emerging categories. There are two specific 
criteria to distinguish categories, internal homogeneity and external heterogeneity. Internal 
homogeneity refers to the requirement that data within each category should belong together 
in a meaningful way. The external criteria are met when there are obvious differences 
between individual categories (130).  
When the manifest analysis was finished, the codes, subcategories, and categories were re-
read, reflected upon, and discussed, as a latent content analysis to extract the latent theme 
(135). The aim of the latent content analysis was to communicate the underlying meaning of 
the text, i.e., what was not explicitly said but ran as a red thread throughout the text. 
Quotations were translated from Swedish into English after the analysis was finished. The 
same procedure was then repeated in Study II. 
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Trustworthiness 
As qualitative content analysis can be regarded as an interpretive method (137). The 
conventional criteria of judging research results (e.g., validity, objectivity) are unsuitable for 
judging the results of the qualitative content analysis. In the qualitative research methods, 
trustworthiness is used as the notion that the interpretation of the research is the most 
probable interpretation of the data (139). Trustworthiness will, however, increase if it also 
allows the reader to look for other interpretations of the findings. There are four criteria that 
are used to evaluate trustworthiness of qualitative methods, credibility, transferability, 
dependability, and confirmability. In the following section, the measures taken for achieving 
trustworthiness in Studies I and II are presented.  
Credibility   
Credibility is the extent to which the study’s results are trustworthy, and believable to others 
(123,135). The sampling of the participants was not random, but rather purposeful, so as to 
interview participants who would like to talk about their experiences. The variation in 
experiences because of the participants’ various ages and a research team with various 
perspectives contributed to a richer understanding of the phenomenon under study. On 
comparing the participants with the non-participants, they were found to be comparable 
regarding age, severity of disease, medical history, and treatments.  
Semi-structured interviews were chosen as the method for data gathering since the aim was to 
describe variability in experiences of living with CAH. The amount of data generated can 
give the reader a notion of whether the data gathering method used can answer the research 
question in the most credible way. Inductive content analysis as a method of analysis method 
was considered to be the closest conformity with the data since the intention was not to derive 
new hypotheses, but to give a rich description of the real-life experiences of women with 
CAH.  
In addition, credibility was also improved by analyst triangulation made in the beginning of 
the analysis for Studies I and II to ensure coding consistency, and by checking 
interpretations against the text. Since credibility also encompasses how well the data, 
categories, and themes match, the entire process is described in detail and quotes are added to 
the description of the findings. Investigator triangulation was also used, to help to ensure the 
integrity of the findings. Thus, the research team consisted of a varied group of individuals, 
representing the medical and research communities, and everyone was involved in 
discussions, scrutiny, and debriefing, surrounding the coding and interpretation of the data, 
thus  
Transferability  
Transferability is an important aspect of trustworthiness because it refers to the question of 
how applicable the results may be to other contexts. The researcher can facilitate and suggest 
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transferability, but it is for the reader to judge, whether the results are transferable or not 
(135). By describing the setting, sample, approach, and analysis in rich descriptions, as well 
as the findings, and by inserting quotes where it is appropriate, the reader is given the 
opportunity to evaluate the extent to which the conclusions drawn are transferable to other 
women with CAH. The transferability of the findings can also be judged by contrasting the 
findings with previous research from similar contexts.  
Dependability  
Dependability can be understood as to the extent to which the results are consistent, in 
relation to the contexts in which they were generated. Dependability is determined by the 
consistency of the study process and thus takes into account the degree to which data change 
over time, and what changes have been made surrounding the analysis during the analytical 
process. Recruiting women from different age groups with different severities of disease, and 
thus different experiences, promoted dependability. Discussions were ongoing in the research 
team with open dialogues about how to judge similarities, and differences in the data, and 
also to avoid preconceptions (140).  
Confirmability  
Confirmability is the extent to which the findings are the results obtained from the study’s 
participants and settings instead of being research-biased. Confirmability has been addressed 
by means of strategies the described above, such as analyst and investigator triangulation to 
reduce the effect of researcher bias (135). Thus, an open dialogue was established between 
the researchers, who also discussed the interpretation of the data until a consensus was 
reached. The confirmability can be understood as the internal consistency in the final 
manuscript, i.e., if the data, the findings, the interpretations, and the recommendations are 
coherent.  
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Reflexivity  
Reflexivity refers to the process of examining the researcher’s perspective, and pre-
understandings of the field of study. All research is influenced by the researchers 
background, feelings, or opinions, and the relationships between participants and researchers 
(141). The researcher’s background will affect the angle, from which and how the 
investigation is performed, and what findings are considered most probable (142). In this 
section, I will try to present my background, and my approach to this research.  
When I entered this project, the interviews had already been performed. At first I was hesitant 
to analyze qualitative data collected by someone else, but since I have a close relationships, 
and open dialogue with the interviewer (main supervisor), I thought, why not? The 
participants’ narratives concerning their experiences are important contributions to both the 
clinical and the research communities.  
In health research, clinical researchers have often been socialized into professional ways of 
thinking (143). As a medical doctor I have, of course, been socialized into the thinking like a 
physician. However, I also have a background in sexual education and norm critical contexts. 
Therefore, I am not unfamiliar with the idea of the interpretative approach, believing that we 
make our experiences in relation to others. Thus, in these studies, I have tried to understand 
the meaning other people give to their surrounding world. You cannot walk in other people’s 
shoes, but you can try to think what it would be like.  
CAH is a disorder that can affect phenotypic traits of a person given excess androgen. Before 
reading the narratives in the interview transcripts, I had never met a woman with CAH. I 
believe this enabled me not to dismiss their described feelings of not looking like a woman, 
or being too masculine, because I did not know what they looked like. In addition, I have no 
personal experience as a physician of caring for patients with DSD. As such, I think that I 
have contributed to the analytical process by not having a caregiver perspective. Thus, I did 
not have any preconceptions about the care given, and I did not have any need to defend or 
argue for pros, or cons of the care process. In contrast, three out of five researches on our 
team are, or have been, in a caregiver position, which of course was an important perspective 
in the analysis which increased the trustworthiness of the findings. 
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5.4 QUANTITATIVE STUDIES 
The following section will address the methods used in Studies III and IV. 
Matched-case cohort study  
Study III was designed as a matched-case cohort study to compare the frequency of 
psychiatric disorders in girls and women with CAH with that of age-matched male and 
female controls. 
Study population and sample 
All Swedish residents are assigned a personal registration numbers (PNR) that is used in all 
official records and registries (144). The PNR makes it possible to follow every individual 
over time and can be used to derive data by linking the population-based registers in Sweden. 
A de-identified version of this personal number was used to link the data from the registries.   
The National Registry of CAH (20,39) was used to identify 306 girls and women with CAH 
with a clinically, and in most cases, genetically proven 21-hydroxylase deficiency. In 
addition, 180 patients had received the CAH diagnosis (ICD-8 codes 255.01, 255.08, ICD-9 
codes 2552, 255C, ICD-10 code E25.0) at least twice in the National Patient Registry (NPR, 
National Board of Health and Welfare); however, on excluding patients who had also 
received a diagnosis of primary adrenal insufficiency (Addison’s disease), acromegaly, or 
malignancy, a total of 43 patients remained and out of them, 29 were female (Figure 12).  
 
Figure 12. The procedure for identifying girls and women with CAH from the National CAH 
Registry and the NPR, in total 335 girls and women with CAH were identified. 
In total, 335 girls and women with CAH born between April 1915, and January 2010, were 
identified (Table 5). The participants’ age in January 2010 was calculated for descriptive 
purposes. Large differences in the survival rate can explain the low median age since a low 
number of individuals survived during the earlier years (20). The girls and women with CAH 
were grouped after clinical presentation and/or known CYP21A2 mutations. Individuals with 
unknown CYP21A2 mutations were given a clinical classification of SW, SV, or NC, if 
clinical data were available, and if they clearly contained information that could be used for 
classification (20).  
National 
registry of CAH 
(n=612) 
Males with CAH 
(n=306) 
Females with 
CAH (n=306) 
CAH diagnosis 
twice in NPR 
(n=180) 
Other diagnosis 
(n =137) CAH (n=43) 
Females with 
CAH (n=29) 
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Table 5. Characteristics of the girls and women included in the study 
Median age calculated from January 2010 
Median age                                  25,3 years  (IQR, 15.8-37.8)  
Born in Sweden n = 302 (90.1%)    
Clinical phenotypes 
n =282 
SW  
n = 135 
SV 
n = 91 
NC 
n = 56  
Most common CYP21A2 
genotypes, n = 237 
Null 
n = 59 
12splice 
n = 67 
P30L 
n = 12 
V281L 
n = 42 
For each case with CAH one hundred female controls (1:100) and one hundred male controls 
(1:100) were randomly selected from the general population (Total population registry, 
Swedish Tax Agency). Controls were matched on year, county of birth, and migration status. 
Controls did not have a diagnosis of CAH. Migration status was defined as being born in or 
outside Sweden. Girls and women with CAH who had immigrated to Sweden were matched 
with female and male controls that had also immigrated, via the Migration Records (Statistics 
Sweden), containing all documented migrations since 1901. Matched controls had to be 
living currently in Sweden at the time of the study. 
The rationale for only including girls and women with CAH in the study population was that 
46,XX individuals with CAH are known to have high prenatal androgen levels, but it is 
unclear whether prenatal androgen levels are elevated in males with CAH (145). Male 
controls were used to test the organizational hypothesis of androgens concerning psychiatric 
morbidity because it stipulates that prenatal androgens would organize the brain in a more 
masculine way, and thus, the girls and women with CAH would show a pattern of psychiatric 
morbidity comparable to that of male controls rather than of female controls.  
Data collection 
The individual PNR of all girls and women with CAH and their controls were used to derive 
data through linkage of population-based registers in Sweden. In order to insure anonymity 
for girls and women with CAH and matched controls, the PNR was replaced with an 
unidentifiable number by Statistics Sweden before linkage of the registers. Only Statistics 
Sweden had access to the code key and thereby the possibility to identify specific patients. In 
other words, it was impossible to go back and forth between the registries and the medical 
records to identify any given individual.  
Information on the included psychiatric diagnoses was drawn from NPR, which contains the 
discharge diagnoses of inpatient care since 1964 and outpatient care since 2001. Since 1987, 
it includes all inpatient care, and since 2001, also outpatient visits including psychiatric care. 
Diagnoses in NPR are coded according to the International Classification of Diseases (ICD), 
a statistical classification system used to group diseases and causes of death. The ICD is a 
standard diagnostic tool used for clinical purposes as well as epidemiology and health 
management (146). The ICD-8, ICD-9 and ICD-10 were used which cover diagnoses from 
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1968 onward according to Statistics Sweden. In addition, to access psychiatric co-morbidity 
in detail, outcomes were subdivided into secondary endpoints (see Paper III)  
The Cause of Death Register (CDR, National Board of Health and Welfare) was used to 
obtain data on completed suicides. The register provides data on all registered deaths since 
1952. Thus, suicidal attempts and completed suicides were analyzed separately when looking 
at psychiatric comorbidity.   
Socio economic status is known to negatively correlate with mental illness (147). To be able 
to adjust the results for socio-economic status, participants’ parents’ highest level of 
education was used as a proxy. The Multi-Generation Register (Statistics Sweden) was used 
to identify parents since it contains connections between index persons (born in 1932 or 
later, or registered in Sweden since 1961) and their biological or adoptive parents. To 
obtain data on the parents’ highest level of education, the Swedish Register of Education 
(Statistics Sweden) was used. 
Data analysis 
The association between diagnosis of CAH and psychiatric outcomes was evaluated by 
conditional logistic regression since it is most suitable for studies in which cases and controls 
are matched individually. SAS version 9.3 was used for all statistical analyses and matching 
procedures. 
Conditional logistic regression is a special type of logistic regression and is used when the 
case subjects with a specific condition (e.g., females with CAH) are matched with controls 
without the condition (e.g., Those without CAH). Conditional logistic regression is used to 
investigate the relationship between outcomes while potential confounders are being 
controlled for. The results were presented as odds ratios (OR) and 95% confidence intervals 
(CI). When it comes to rare disorders odds ratios are said to be equal to risk ratios. The 
results were adjusted for parents’ highest education, a proxy for socioeconomic status.  
Data were stratified based on different aspects, known and unknown genotype, known and 
unknown phenotype. The group with a known genotype was stratified with regard to 
mutation (null, I2splice, I172N, and, P30L), and the known phenotype group was stratified 
according to clinical severity (SW, SV and NC). In addition, data were stratified to see if 
subjects had received their psychiatric diagnoses before or after 18 years of age, which, in a 
Swedish setting, can correlate with pediatric or adult care. Data were also stratified into 
before and after the introduction of nationwide neonatal screening in Sweden in 1986, to see 
if the frequency of psychiatric diagnosis was associated with earlier diagnosis, and thus 
treatment. Lastly, the data were stratified according to if subjects had received their 
psychiatric diagnosis <12.0 years of age, between 12.0 - 17.9 years of age, or ≥18.0 years of 
age, since this would give clinicians a better overview as to when the psychiatric conditions 
were diagnosed.  
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Cross-sectional study 
Study IV was designed as a cross-sectional study to answer the questions of whether the 
psychiatric disorders in women with DSD and women with POI differ from those of 
population-derived female controls. It was also hypothesized that congenital hormonal 
imbalance (e.g., CAIS and CGD) or acquired hormonal imbalance (POI) could affect the 
frequencies of psychiatric disorders differently. 
Study population and sample 
Women with CAIS, 46,XX CGD, 46,XY CGD, and POI were recruited via their treating 
gynecologist as part of a Swedish multidisciplinary study focusing on women with congenital 
and acquired hormonal imbalances. If they agreed to participate, a research nurse or midwife 
would call them and book an appointment for the research reception at the Karolinska 
University Hospital. Inclusion criteria were being Swedish-speaking and ≥18 years of age.   
The Total Population Registry was used to find suitable controls to the participants with 
either DSD or POI. The personal registration number (PNR) of included women was used to 
select population controls. An invitation letter was sent to the women living in the greater 
Stockholm area with the consecutive PNR in the Total Population Registry. The purpose of 
this procedure was to recruit population-derived controls born on the same year and date as 
the included women with DSD, or POI. If women who were invited declined participation or 
did not answer, the next woman with a consecutive PNR in the Total Population Registry 
living in Stockholm was invited and so on. If they were willing to attend a research nurse or 
midwife would call them and make an appointment for the research recipiency at 
Kvinnohälsan, Karolinska University Hospital. In the end seven women had two population-
derived controls, and 47 had one population-derived control, which explains the slightly 
younger age among controls. In total 33 women with DSD, 21 women with POI and 61 
population-derived controls were recruited (Table 6).  
Table 6. Characteristics of the study sample 
    Highest completed level 
of education 
  Sample 
size, n 
Age (standard 
deviation, range) 
In a 
relationship 
Secondary 
education 
University 
Women with DSD 33 32.8 (9.4, 21-57) 21 (64%) 15 (45%) 18 (55%) 
Women with POI 21 32.3 (6.6, 21-44) 15 (71%) 9 (43%) 12 (57%) 
Controls 61 31.8 (8.2, 21-57) 46 (75%) 22 (36%) 38 (62%) 
Subgroups of DSD: 
Women with CAIS 20 34.1 (10.1, 21-57) 10 (50%) 11 (55%) 8 (40%) 
Women with 46,XX 
CGD 
7 28.0 (4.6, (23-36) 5 (71 %) 2 (29%) 5 (71%) 
Women with 46,XY 
CGD 
6 34.2 (10.9, 24-47) 3 (50%) 2 (33%) 4 (67%) 
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Data collection 
Study IV was designed as a cross-sectional follow-up study using The MINI+, International 
Neuropsychiatric Interview plus (MINI+), a brief structured diagnostic psychiatric interview 
for generating DSM-IV diagnoses convertible to ICD-10 criteria of psychiatric disorders 
(146,148,149). Validity and reliability studies have compared MINI with more extensive 
systematic interviews (e.g., SCID-P and CIDI) and, in comparison, MINI shows a high inter-
rater validity for anxiety and affective disorders. It can also be administered in a shorter 
period of time, and has good acceptance among patients (148,150–153). The MINI+ is an 
extended version of the MINI that includes specific phobias and an expanded module for 
psychosis. The MINI+ consists of 15 modules corresponding to diagnoses and collects 
information regarding past and current symptoms in 23 axis-I problem areas. It is a widely 
used instrument in both clinical and research settings, including patients with somatic 
conditions (154,155). The PhD student conducted the MINI+ evaluation in the majority of 
cases and the duration of the interviews were between 15 minutes and one hour. If any 
questions arose regarding the diagnosis the case was discussed in the research team.  
In addition to the MINI+ evaluation, the women were also asked to fill out a web-based 
survey questionnaire containing questions concerning the level of education, occupational 
status, relationship status, and medical history regarding psychiatric morbidity. Data 
collection was ongoing from 2011 to 2016. The MINI+ evaluation was an integral part of the 
multidisciplinary study in which women with CAIS, 46,XX CGD, 46,XY CGD, and POI 
underwent one day of medical and psychological examinations at the Karolinska University 
Hospital, Stockholm, Sweden.  
Data analysis 
The statistical analysis was carried out using IBM SPSS Statistics 22 and descriptive statistics 
were used. For categorical data, Pearson’s χ2 Test was used for cross-tabulation tables to 
assess differences in the frequency of psychiatric disorders across groups. For groups equal to 
or smaller than five cases Fisher's exact test was used. In addition, significant findings 
(p<0.05) were included in a logistic regression to calculate odds ratios (OR) for the 
significant differences. An OR with a 95% confidence interval not including 1 was 
considered significant.  
Subgroup analyses were performed for women with CAIS, using the same method as in the 
primary analysis. However, women with 46,XX CGD and 46,XY CGD were excluded from 
subgroup analyses because of small groups and thus low power.  
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5.5 ETHICAL CONSIDERATIONS 
Persons with DSD carry a significant psychological burden. Thus, it can be considered 
unethical not to learn more about what can be done do to improve their care. For Studies I, II 
and IV all persons have signed a written consent form before participation in the study. The 
participants were also informed that they could withdraw from the study at any time and that 
all data would be anonymized and kept safely. All women were granted confidentiality and 
travel expenses were reimbursed. Moreover, all studies had been granted ethical approval by 
the Regional Ethics Committee at Karolinska Institutet. 
Representatives from the Swedish patient organization, as well as DSD patient organizations 
in other countries, have expressed a wish for more follow-up studies. One may fear that it 
would be intrusive to ask these individuals intimate questions about personality, cognitive 
function, and sexual matters, and, not least to bring up the subject of atypical sex 
development. However, some of the participants expressed the opinion that they are 
constantly aware of this anyway, and it may even be a relief to talk openly about it and to 
learn more about their diagnosis. The studies are also facilitated by the fact that clinicians 
caring for these patients are themselves involved in the project and thus can recruit patients 
and take the individual patient’s best interest into account. The interviews for Studies I-II 
were all carried out at a time and place that was most convenient for the interviewee to make 
her feel safe and comfortable.  
For Study III, a prerequisite to obtain approval by the Ethics Committee was that all 
included individuals were anonymized to protect the integrity of the included individuals and 
thus, all analyses were made on anonymized data and the code key was kept by Statistics 
Sweden.  
Participants in Study IV were included as a part of a larger study. All participants and 
controls received remuneration (1000 SEK) for participating, which was intended to cover 
travel expenses and lost income. The women could choose to participate in some or all parts 
of the project. They were offered follow-up and referral for further investigation if they met 
the diagnostic criteria for a psychiatric disorder or if they desired counseling.  
Many women expressed a wish to partake of the results and appreciate the increased 
information and knowledge they gained by participation in clinical studies. We have 
presented the results for both adult women and for parents to children with a DSD, and we 
plan to invite interested participants, other patients, relatives, and patient support groups to a 
seminar when more results from the large follow-up study (Study IV) are published. 
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6 FINDINGS 
The findings in this thesis will be presented according to the specific objectives for each 
study, as shown in table 7.  
Table 7. Schematic overview of main findings in Studies I-IV  
 Specific 
objectives 
Research 
question Approach Findings 
I To explore 
women’s 
personal 
experiences of 
living with CAH 
How do women 
with CAH 
describe their 
experiences of 
having CAH, 
and the care 
given? 
Qualitative Participants experience information sharing as 
being facilitated by CAH-specific knowledge. 
Genital demonstrations are experienced as 
traumatic. The idea of being healthy varies 
between the participants. Some never feel 
healthy because of CAH and some feel 
healthy because of correct medication. 
Research is considered to be important, but it 
reinforces normative gender roles. The 
participants describe different types of 
struggles against shame and stigma. 
II To explore 
women’s 
personal 
experiences of 
living with CAH 
How do women 
with CAH 
describe their 
experiences of 
identity 
formation, 
sexuality, and 
parenthood? 
Qualitative Participants describe feeling different because 
of CAH. Feeling like a woman is threatened 
by normative expectations of femininity. 
Intimate relationships are hindered by sexual 
difficulties, and insufficient knowledge. 
Fertility is not taken for granted and the wish 
for children varies. Participants have shifting 
perspectives on their condition depending on 
their experiences and different situations in 
life.  
III To increase 
knowledge of 
psychiatric 
disorders among 
women with DSD 
What is the 
frequency of 
psychiatric 
disorders in a 
Swedish cohort 
of girls and 
women with 
CAH compared 
with matched 
controls? 
Quantitative Girls and women with CAH have a higher 
risk to having received any psychiatric 
diagnosis. In particular they have a higher 
risk of alcohol misuse disorders, with girls 
and women with the null mutation having the 
highest risk. In addition, they also have an 
increased risk of stress and adjustment 
disorders.  
IV To increase 
knowledge of 
psychiatric 
disorders among 
women with DSD 
Is the frequency 
of psychiatric 
disorders in 
women with 
DSD different 
from that of 
women with 
POI and 
matched 
controls?  
Quantitative  
 
Women with different DSD have a higher 
lifetime risk of any psychiatric disorder, and 
in particular mood disorders and anxiety 
disorders, compared to unaffected women. 
Women with POI did not have a significantly 
higher risk than women with a DSD or 
controls.  
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6.1 PERSONAL EXPERIENCES OF LIVING WITH CAH  
Studies I and II  
The qualitative content analysis of data in Studies I and II yielded both manifest and latent 
findings, the variations of findings are shown in Table 8.  
In both studies, a latent analysis was performed and the emerged latent themes were 
identified as striving for dignity, individuality, and self-agency, but also a struggle against 
shame (Study I) and shifting perspectives on the impact of CAH on the individual experience 
of living with CAH (Study II). The latent themes comprise underlying assumptions of 
wanting to be seen as a human being and not as a condition. The struggle against shame was 
more pronounced for different participants and in different periods of their lives, which was 
also the case for the shifting of perspectives. CAH could be regarded as just something that 
they had to take medication for and, as long as they did, they were healthy. On the other 
hand, CAH was sometimes regarded as being the explanation for all obstacles they have met 
in their lives. It was interpreted from the analysis that the perspectives shifted, depending on 
what happened and in what period of life the women found themselves.  
Parental secrecy was described as something that was shame-inducing: “It felt like she (my 
mother) did not want anyone to know, and that feeling is still with me today.” The first years 
of having CAH were understood through the parents’ experiences of loss of control, 
frustration surrounding decision (e.g., surgery), and uncertainty of how to tell friends and 
family. The participants stated that the feelings conveyed by their parents had affected their 
own ability to cope with the condition. 
Parental support was described as being important to help with information disclosure and the 
understanding of CAH, “They (my parents) told me that I have a fault in my adrenal glands 
and that I can’t make cortisol and that makes me loose salt and I can die without treatment.” 
Information sharing with peers was negotiated between disclosure and the potential risk of 
stigma: “This disorder is so tough because you can’t tell anyone about it because it is so 
strange and difficult and unpleasant.” However, disclosure could also be considered as 
potentially life saving, since their peers could come to understand acute treatment, and by 
disclosing, the participants’ experienced inclusion and understanding by their peers.  
When asked about peer support groups, the participants explained that they often refrained 
from joining support groups because they did not identify with other persons with CAH, or 
did not want to be identified as someone with CAH. However, some participants were 
involved in support groups and described them as important for adjustment and a feeling of 
belonging. 
The positive interactions with medical professionals included gaining knowledge and being 
an active part of the discussions surrounding treatment regimens and management. In 
addition, the doctor-patient relationships was also looked upon as salient if the clinician 
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understood that CAH is not just an endocrine condition, but also a condition that affects 
emotions, cognitions, identity, and relationships: “We are also humans, we who are sick.” 
However, several participants explained that they refrained from acquiring knowledge about 
CAH because they did not want to feel sick or deviant: “You want to be a normal human 
being”. Thus, the participants explained that they had no knowledge of previous surgery and 
that they had learned such things as adults, e.g., that their clitoris had been amputated by 
reconstructive surgery when they were born, “I actually believed that I had a clitoris, but 
obviously I don’t.”   
Being exposed in the doctor- patient meeting was experienced both as children and as adult 
women. Firstly, the participants had experienced that they did not understand why they were 
frequently admitted to hospital as children. Secondly, the absence of CAH-specific 
knowledge among medical professionals was considered stressful, for example, participants 
felt that they had to take responsibility for the right acute treatment, and also to explain that 
being born with ambiguous genitalia does not equal sex reassignment. Thirdly, genital 
examinations during childhood were perceived as the main focus of physicians and that these 
examinations were experienced as a threat to personal integrity and that the parents were 
unable to provide adequate protection, “I always had to wash ‘down there’ before going to 
the doctor.” Lastly, both as children and as adults, the participants had been subjected to 
situations where they were expected to show their genitalia to medical professionals and 
students, or to be photographed naked. The overall impression among the participants that 
this was expected since they have a rare disorder and thus, a responsibility to increase 
knowledge among medical professionals and students: “So that there can be an improvement 
compared to when I was a child.” However, the demonstrations and photography were 
experienced as safe, but also as traumatic and since the medical incentives were not always 
clearly communicated, some participants believed that it was mostly done out of the 
physician’s curiosity. In addition, this resulted in avoidance of, e.g., regular gynecological 
exams and fortified feelings of being deviant: "It confirms that it is not normal, that you need 
to take a photo of it.” 
Similarly, participation in research studies was considered a way to enhance care for other 
patients: “I think that it is okay if you can give something to others in some way.” In addition, 
it was important to participate in order to share different experiences and to show that women 
with CAH are different individuals: “We who are not tomboys have only taken up a small 
space.” When reading research results it was considered informative if you could recognize 
yourself in the findings. However, research was thought of as being biased and reinforcing 
the gender prejudice that surrounds CAH, e.g., interpretations of gender behavior, such as: “If 
you like cars it is only because of the disorder /…/.” In addition, research was regarded as 
only pointing out what was wrong or abnormal, instead of focusing on how to improve 
management and treatment.  
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Medication and surgery were described with shifting perspectives. Medication could be 
experienced as something that facilitated living a normal life and in contrast, something that 
made you never feel healthy. In conformity with medication, early genital reconstructive 
surgery could be considered to facilitate feeling ‘normal’ but could also fortify the notion of 
having to be corrected. Some participants wished that they could have decided on surgery for 
themselves. Following surgery, some participants used dilators to preserve vaginal size, 
which was experienced as time-consuming, stressful, and painful, but also important to 
facilitate having ‘normal’ (i.e., penetrating) sex. Vaginal size and disclosure of being born 
with a DSD could be regarded as a hinder to starting a romantic relationship: “I do not dare 
living my life to the fullest and starting a relationship because my vagina is too tight.” 
However, women who were in a current relationship experienced that vaginal size was not a 
problem, and neither was disclosure about CAH or surgery. Experiences surrounding sexual 
activities were varied among the participants, ranging from being totally uncomplicated to 
something experienced as painful and never feeling lust, but also that sexual activities were 
unachievable. Same-sex relationships were considered easier since this did not imply 
penetrating sex.  
Feeling different was a common experience during childhood, mostly because of frequent 
hospital visits but also because of early puberty: “It was not that I was taller than everyone 
else, it was that I went through puberty, got hair on different places.” Some participants had 
experienced bullying, which made them question whether CAH was visible on the outside: “I 
thought that it is visible on the outside even though I know that it wasn’t.” 
The focus on gender-related issues and gender atypical behavior in CAH research, and also in 
clinical management, made the participants reflect upon their female identity. Women with 
CAH have carelessly been called tomboys, given the findings of male-typical play behavior 
and male typical interests (69,71). This could be considered to be positive, and some 
participants described themselves as tomboys since they identified as a woman who prefers 
socializing with men and has typically traditional masculine hobbies. However, they did not 
associate this with CAH: “I know many women who love cars just like me, and they do not 
have CAH.” In contrast, “tomboy” was experienced as a limiting term and that giving women 
with CAH the label of tomboys excluded women who do not identify as tomboys from the 
group of individuals with CAH.  
Supplementing the above, some did not experience problems with their gender identity while 
others described feelings of not being a real woman and not being feminine enough. Not 
being interested in make-up or feminine clothing was experienced as problematic since these 
accessories could help them fit into the normative picture of “a real woman”. Some 
participants had always been questioned about their female gender and had experienced being 
mistaken for a man, which led to questions about what their true gender identity is: “Maybe I 
am not a woman, but I feel like a woman.” 
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Parenthood could be regarded as a confirmation of being a real woman and, for others, it did 
not change anything regarding their self-perceived gender identity. In addition, the lack of 
female self-identification was considered to be troublesome when raising children: “I don’t 
feel like a female role model for my daughter because I never wear feminine clothes or make-
up.” Thinking of parenthood and children could also involve fear of infertility or that the 
child would be born with CAH or not be healthy: “If I have children, they probably won’t be 
completely healthy; no one ever said anything about that, but I think so.” 
In addition, biological parenthood was not regarded as obligatory, and some participants had 
no longing for becoming pregnant or having biological children; however, they enjoyed 
living with children. Some interpreted the absence of a wish for children as being because of 
CAH: “I do not have any desire to have children; maybe I have unconsciously put it away 
because of my disease – but I have always preferred cars to dolls.” 
Table 8. Examples of the variation of experiences in the categories of Studies I and II  
Manifest analysis 
 Categories Subcategories  Variation  
Study I  Information     
  Health 
professionals 
Inclusion çè Exclusion 
  Parents and 
peers 
Secret çè Public 
 Exposure     
  Focus on 
genitalia 
Safe çè Exposed 
  Photography Autonomy çè Dependent 
 Health     
  Medication Healthy çè Never healthy 
  Surgery Facilitating çè Complicating 
 Research     
  Research 
subjects 
Important for 
future care 
çè Focus on 
deviation 
  Interpretation 
of research 
Represented çè Not 
generalizable  
Study 
II 
 
Forming identity 
    
  As a girl  Unaffected çè Bullied 
  As a tomboy 
As a woman 
Recognition 
Good enough 
çè 
çè 
Limiting 
Not enough 
 Establishing relationships     
  Intimate 
relationships  
Safe çè Exposed 
  Parenthood Autonomy çè Dependence 
Latent analysis 
 Themes     
Study I Struggle against shame  Dignity 
Self-agency 
Individuality 
çè Shame 
Stigma-
conscious 
Study 
II 
Shifting Perspectives   CAH in the 
background 
çè CAH in the 
foreground 
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6.2 PSYCHIATRIC MORBIDITY IN WOMEN WITH DSD 
In summary, the results showed that the frequencies of psychiatric disorders are increased 
among women with different DSD, compared to population controls. 
Study III  
In Study III, girls and women with CAH had a doubled risk of having received a diagnosis 
of any psychiatric disorders in the National Patient Registry compared to both male and 
female population controls (Table 9). Girls and women with CAH also had an increased risk 
of mental and behavioral disorders due to psychoactive substance use, particularly alcohol 
misuse, compared with both female and male population controls. In the sub-analysis of 
anxiety disorders, there were also high risks of stress-related and adjustment disorders 
compared to female controls [OR 2.1, (95% CI 1.3-3.6)]. 
Table 9. Psychiatric disorders in girls and women with CAH compared with controls (1:100). 
Presented as odds ratio, OR, (95% CI). OR=1 means no difference. 
 CAH girls and women, n=335 
 Female controls  Male controls  
Any psychiatric disorder 1.9 (1.4-2.5)* 2.2 (1.7-2.9)* 
Mood disorders 1.5 (0.9-2.4) 2.9 (1.8-4.6)* 
Anxiety disorders 1.5 (1.0-2.3) 2.7 (1.8-4.2)* 
Alcohol misuse 2.8 (1.7-4.7)* 2.1 (1.2-3.5)* 
* p < 0.05   
When stratifying by age, only women 18 years or older had a significant increase of any 
psychiatric morbidity, compared to female controls. Stratification before or after the 
introduction of neonatal screening in 1986 or known and unknown genotypes or phenotypes 
did not change the risk estimates. On controlling for parents’ highest level of education, the 
increased risk for any psychiatric disorder, anxiety disorders, and alcohol misuse was still 
significant in comparison with female controls, but not compared to male controls (Table 10). 
Table 10. Psychiatric disorders in girls and women with CAH compared with female controls (1:100), 
presented by strata and adjusted for the parents’ highest level of education.  
Presented as the odds ratio, OR, (95% CI). OR=1 means no difference.  
 Stratified by  Adjusted for 
  
≥ 18 years 
 
Born before 
1986 
 
Born 1986 or 
after 
Parents’ highest 
level of 
education 
 
Any psychiatric 
disorder 
Female controls Female controls Female controls Female controls 
1.9 (1.4-2.7)* 1.7 (1.2-2.5)* 2.1 (1.2-3.3)* 1.9 (1.4-2.5)* 
Mood disorders 1.7 (1.1-2.8)* 1.7 (1.0-2.8)* 1.0 (0.3-3.1)* 1.5 (1.0-2.4)* 
Anxiety disorders 1.7 (1.1-2.7)* 1.6 (1.0-2.6)* 1.2 (0.4-3.0)* 1.5 (1.0-2.3)* 
Alcohol misuse 3.0 (1.6-5.8)* 2.5 (1.2-5.2)* 3.2 (1.4-6.9)* 2.2 (1.3-3.7)* 
* p < 0.05     
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In-depth analyses of the data regarding phenotype groups showed that the subjects with SW-
CAH had twice the risk of any psychiatric disorder, compared to female controls. Individuals 
with SW-CAH were also associated with three times the risk for alcohol and drug misuse 
disorders, compared with unexposed female controls. Girls and women with SV-CAH had a 
higher risk of alcohol misuse. The subjects with NC-CAH had a ten times increased risk for 
specific phobias. On analyzing data regarding genotype groups, the girls and women with the 
most severe genotype, including the null mutation, had more than a five times higher risk for 
substance misuse disorders [OR 6.7, (95% CI (2.6-17.8)], and an almost ten times higher risk 
for drug misuse [OR 9.8 (95% CI 2.9-33.7)] compared with female controls. Subjects with 
the null genotype were also associated with a higher risk for ADHD, but the higher risk was 
only true for subjects born before 1986 when data were stratified in accordance with the 
introduction of screening that year. (See Paper III).  
  45 
Study IV 
In Study IV, 85% of women with DSD fulfilled criteria for a psychiatric condition, 
compared with 76% of the women with POI and 54% of population-derived controls. They 
also had a significant increase in the risk for any psychiatric morbidity [OR 5.1, (95% CI 1.7-
14.9)] and in mood disorders [OR 2.7, (95% CI 1.1-6.5)] and anxiety disorders in particular 
[OR 4.2, (95% CI 1.69-10.3)] compared to population-derived controls. In addition, there 
was a 20-fold increase in the risk for an obsessive-compulsive disorder (OCD) in women 
with DSD, compared to controls [OR 21.1, (95% CI 2.5-175.3)]. However, co-morbidity 
involving DSD and OCD encompasses few individuals (n = 7 women with DSD). For 
women with POI, there were no significant findings on comparing women with DSD, or on 
comparing with controls (Table 11).  
Table 11. P-values for differences in frequencies of psychiatric disorders among women with DSD 
compared with women with POI and age-matched controls. Odds ratios are presented for significant 
differences between DSD and controls. OR=1 means no difference. *= p <0.05 
 DSD (n = 33) POI (n=21) 
 POI Controls OR (95% CI) Controls 
At least one psychiatric disorder 0.476 0.003* 5.1 (1.7, 14.9) 0.07 
At least two psychiatric disorder 0.451 0.008* 3.2 (1.3, 7.8) 0.29 
Major depressive episode 0.775 0.030* 2.7 (1.1, 6.5) 0.14 
At least one anxiety disorder 0.403 0.003* 4.2 (1.7, 10.3) 0.16 
Obsessive compulsive disorder 0.131 <0.000* 21.1 (2.5, 175.3) 0.26 
Previous contacts with healthcare because of psychiatric symptoms were reported by 64% of 
the women with DSD, and all 64% met the criteria for at least one current or lifetime 
psychiatric disorder in the MINI+. This was numerically higher than in women with POI and 
controls (43% and 40%, respectively), but not statistically significant. This was also true for 
current psychopharmacological treatment. 
Subgroup analyses showed a higher risk among women with CAIS (n=20) for any psychiatric 
disorder [OR 3.5, (95% CI 1.1-11.7)] compared with population-derived controls. Women 
with CAIS also showed a higher risk to fulfill criteria for depression [OR 3.1, (95% CI 
1.1,9.3)], and for an OCD diagnosis [OR 15.3, (95% CI 1.6-146.1)] in comparison with 
population controls. 
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7 DISCUSSION 
This thesis set out to investigate psychological and psychiatric aspects concerning women 
with disorders of sex development. The specific objectives were to explore the women’s own 
experiences of having CAH and to increase knowledge regarding psychiatric morbidity in 
women with different forms of DSD. By interviewing women with CAH, several important 
factors could be identified that had an impact on these women’s psychosocial adjustment. 
Psychosocial adjustment among these women is dependent on several factors, such as 
interactions with healthcare providers, support from family and peers, information sharing, 
and attitudes in society. In addition, by linking individuals from the nationwide CAH 
Registry to Swedish nationwide registries and performing structured clinical assessments in 
women with DSD, the different DSD can be linked to psychiatric disorders. The discussion 
around the findings is presented according to the specific objectives.  
7.1 PERSONAL EXPERIENCES OF LIVING WITH CAH 
During the past decade, more attention has been paid to psychological outcomes in 
individuals with CAH. There is also a wider interest in trying to understand what comprises 
different outcomes in psychological and psychosocial adjustment in persons with CAH and 
other DSD (76,156,157).  
When this thesis project started there were few studies that had explored the experiences of 
the care given (97,158). Even though many of the aspects that women brought up in the 
interviews for Studies I and II are not entirely new, but they are important because they add 
valuable details that are useful for information purposes and for understanding the variability 
in CAH and other DSD, regarding psychological outcomes, and can potentially improve 
clinical management strategies.  
The importance of knowledge 
The results of a Swedish study of nine young women with CAIS and gonadal dysgenesis, 
exploring the experience of receiving a DSD diagnosis, implied that all women had different 
unanswered questions after consultation, and that clinicians need to explore individual 
circumstances surrounding each person (159). Given that CAH and other DSD are rare and 
complex disorders, age-appropriate information and a proper language to describe the 
conditions are important for conveying correct knowledge and thus avoiding negative 
judgments. Similarly, it has been reported that, with differentiated medical knowledge, 
women with DSD can describe themselves as “differently normal” or “normally different”. 
Where the first referring to presenting oneself as another kind of normal and the second to the 
fact that we are all different (160).  
The previously prevailing notion that a knowledge of different genitalia and previous 
reconstructive genital surgery could make adjustment difficult led to a culture of secrecy 
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between medical professionals, parents, and patients (161). This is, for example, in line with 
the participants’ descriptions of learning first as adults, that they did not have a clitoris. This 
nondisclosure of diagnosis-related information is also described by the participants as a result 
of experienced parental secrecy. In line with the findings in Study I, parents have been 
described as important sources of information for patients with CAH (97,162), and it is now 
known that the ability of the parents to cope with CAH affect the child’s adjustment 
(163,164). In addition, knowledge of the condition is important for facilitating adjustment 
(163,165). 
Disclosure of a DSD diagnosis has been described as a conflict between accessing social 
support and protect privacy among both parents and the affected individuals (95,97,99,166). 
For example, young women with DSD perceived risks of sharing aspects of their conditions 
with others and they tried to learn how to keep themselves safe until they understood how 
their information would be received (167). Providing parents and individuals with DSD with 
information-sharing strategies is important since information-sharing and disclosure can 
facilitate social support (168). Experiences of social support and treatment experiences have 
been associated with psychological outcome during all stages of life (169). Previous research 
have shown that peer support groups are linked to positive adjustment in chronic conditions, 
for both the affected persons and the parents (170). However, some participants in Study I 
were hesitant to engage in support groups since they did not want to be recognized as 
someone with CAH. 
Similar experiences in persons with diabetes type 1 
The experiences of information disclosure described by women with CAH are similar to the 
experiences of individuals with diabetes mellitus type 1. Similarly, this is another potentially 
life-threatening condition that requires life-long medication, with the difference that diabetes 
is a well-known disease in society (171,172). In a previous interview study, individuals with 
diabetes mellitus type 1 reported that they did not feel shame but that they were angry 
because of the stigma that they had experienced when disclosing their condition (172). 
In contrast to DSD, a Google search for diabetes does not reveal pictures of virilized genitalia 
or naked female bodies. This substantial difference from diabetes is what might make 
disclosure of having a DSD shameful and stigmatizing. To overcome the internal shame 
related to the disclosure of having a DSD that can involve different genitalia, norms and 
beliefs about “normal” bodies needs to be recognized (160,173). These norms and beliefs 
needs be discussed among researchers and health professionals as these norms underpin 
society and in extension, research and practice, and thus affect parents and patients (173).  
Lack of knowledge among health professionals 
In addition to critically questioning norms and beliefs, the lack of DSD-specific knowledge 
among health professionals was described as being stressful among participants. It has been 
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previously reported that it is important that clinicians do not assume that all individuals with 
CAH present with the same concerns (158). Previously, satisfaction with the care has been 
correlated with psychological well-being in persons with CAH (174). A lack of knowledge 
among health care professionals have also been described by women with other DSD (166). 
Continuous education of both health professionals and parents, as well as patients, has been 
suggested to further facilitate adjustment (156,175).  
Genital examinations and surgery 
Given that CAH affects the development of external genitalia, genital examinations have 
been used both as treatment controls and for the purpose of educating health professionals on 
rare disorders (176). Genital examinations are described as being traumatic and as fortifying 
the feeling of being abnormal. In line with these findings, a new study has shown that genital 
examinations during childhood and adolescence were experienced as being strongly 
stigmatizing, especially when combined with the teaching of medical staff (177). This implies 
that genital examinations should be minimized, which is in line with current management in 
Sweden (178) 
In addition, the experience of genital surgery was varied: it could be considered to either help 
or impair adjustment among the participants, depending on whether genital surgery was 
regarded as something that facilitates the feeling of being normal or that it reinforces feelings 
of abnormality. In the same way, among women with DSD, the psychological consequences 
of gonadectomy (surgically removal of the gonads) depend on the social perception of the 
surgery (96,109). Some individuals perceive that they have been “corrected” and others that 
they have had a malfunctioning organ at risk of malignancy removed.  
In Studies I and II, the participants had had surgery at an early age without consent and are 
now living as adults. Today, the discourse determining the clinical practice involving DSD is 
changing toward a demand for informed consent for all irreversible interventions (161), 
which might help decrease the psychosocial burden after surgery. Nonetheless, psychological 
support and discussions around the dual perspective of surgery are needed before and after 
surgical interventions to aid psychological adjustment.  
Psychosexual adjustment 
To supplement the above, sexual behavior may be influenced by emotions and cognitions 
related to having a condition that affects the external genitalia, and that this affects sexual 
responses by increasing anxiety about sexual performance (111). It is, however, unclear 
whether this relates to the initial malformation, the outcome of the surgical procedure or the 
genital surgery itself (97). Medical controls during childhood and adolescence have also been 
focused on the genital status, thereby fortifying feelings of not being normal, as described 
before. Sexual difficulties reported by the participants were related to having a tight vagina 
and a need to dilate. However, concerns about pain and difficulty of penetration and about 
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normality in relation to the genitalia are also common among women in the general 
population (179).  
Such concerns may have an added impact on women with CAH because their condition 
necessitates regular hospital visits, lifelong medication, and sometimes surgery. As has been 
asked elsewhere (97), could hearing that one is too tight and knowing that something is, or 
was, wrong “down there” affect the sexual adjustment? Could the notion “I know that I do 
not have a clitoris” be enough not to be able to have an orgasm? In other words, is there a 
psychological component of dissatisfaction with sexual activities among women with CAH? 
If so, would psychological support, increased knowledge, and refined coping strategies 
improve their sexual satisfaction? 
In addition, a more differentiated sexual education, challenging assumptions about female 
bodies and, including a norm critical discourse, may help women with DSD to make sense of 
their bodies (160,180). Raised public knowledge about physical variations of the body, and 
different ways of sex development can also help to make DSD less difficult to talk about and 
facilitate peer support. Likewise, raised awareness about what it means not to fit into a binary 
model of biological sex is needed (181). 
To be a woman with CAH 
To become a woman, or the concept of female embodiment, was described by Simone de 
Beauvoir as “one is not born, but, rather, becomes a woman” in The Second Sex, first 
published in 1949 (182). Female embodiment is used in critical feminist theory in discussion 
differentiating between gender and sex, and what makes a woman (183,184). Women with 
CAH describe that motherhood is a confirmation of being a woman, contrasting with men 
who can’t give birth. In doing so, they describe the notion that a woman is someone who can 
reproduce. Likewise, women with the XY karyotype describe how learning about the 
condition, and that it might involve internal male reproductive organs, can challenge gender 
identity and the notion of being female (96). In addition, female embodiment is also 
described “Maybe I am not a woman, but I feel like a woman” which can be understood in 
relation to the theory of multifactorial gender identity (185–187). According to the 
conceptualization of the theory of multifactorial gender identity, gender identity comprises a 
person’s self-perceptions of gender typicality, gender satisfaction, and perceived pressure to 
comply with gender stereotypes (185–187). The participant described experienced gender 
atypicality, but, at the same time, content with her gender as a woman. It can also be 
speculated that some women with CAH experience significant social pressure to behave 
“femininely”. However, it is not only the women’s own self-perception of gender that is 
questioned, there are also experiences of being mistaken for a man. This is also described by 
other women with CAH (188) resulting in internalizing stigma and shame.  
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Similarly, the label “tomboy” in relation to CAH referring to girls or women who behave like 
boys or men and thus challenge some theories of sex-typing (189), were experienced 
differently among the participants. It was considered to be a correct label, but also as a 
limiting term that excluded more gender-typical women from the CAH patient community. 
However, in a study on tomboys the “gender identity scores” of CAH girls were more 
gender-typical than those in a sample of girls without CAH, who were considered tomboys 
and recruited through newspapers (189).  
Some participants described that children could be a confirmation of their being a woman, 
but some participants also stated that they did not have a wish for biological children or to 
become pregnant. However, a lack of knowledge was also described, such as whether or not 
their children would be healthy or whether they would also have CAH. These are 
misunderstanding, children to women with CAH have a normal development (190). In order 
to develop CAH one mutated gene is needed from each parent, and therefore, genetic 
counseling should be offered to patients planning for children (18).  
Psychosocial factors, such as less of a wish for children, have previously been suggested to 
partly explain the low pregnancy rates among women with CAH (40,41). If the low rates are 
also are caused by a lack of knowledge, health professionals have another task to deal with 
since it is known that well-treated women with CAH have equal fecundity rates, i.e., the 
possibility to reproduce, equal to those of women without CAH (34,42).  
A potential CAH-paradigm 
Some participants base their knowledge on inaccurate facts (e.g., my children will not be 
healthy), and this leads them to interpret the world through a CAH-paradigm, in the sense 
that CAH is overrepresented as the most possible cause or explanation for different 
experiences. By applying labeling theory additional insights can be obtained. It states that 
individuals are socially “tagged” with a label when they deviate from the norm, and the more 
attention that is paid to the label, the more individuals will identify with this label (191). 
Consequently, one could argue that CAH is used as an explanation by some participants since 
women with CAH have been exposed to research studies looking at CAH as a cause of e.g., 
gender identity, gender role behavior, choice of occupation, and choice of hobbies 
(69,70,75,192). It has also been suggested that much research uses CAH as the most plausible 
explanation even though the results might not be caused by the condition itself but mediated 
by experiences and consequences of living with CAH (76). In that sense researchers in the 
field of CAH are also affected by a CAH-paradigm. To counteract this phenomenon, men 
with CAH can be used as controls since CAH give rise to the same somatic challenges such 
as lack of adrenaline (epinephrine), life-long treatment and the risk of salt-crisis due to simple 
infections. Patient involvement in setting the research agenda might also contribute to 
changes in what type of research questions are asked, how the results are understood and 
what the future caretaking of all DSD patients may include (173,193).  
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Moreover, as researchers it is important that we give individuals with CAH and other DSD a 
way to “make sense” of their condition, and to help them find fair explanations of what 
makes them e.g., “normally different” or “differently normal” (160), and to help them 
navigate the research around DSD and what is applicable to the individual person and what is 
of interest for the understanding of biological concepts (e.g., sex hormones and gender 
behavior).  
In conclusion, the analysis of individual experiences of women with CAH shows that they are 
a diverse group of individuals and that their different needs should be prioritized when 
providing care. Health professionals can help them to navigate trough the trajectory of their 
condition, support them at transitions and help them make sense of their condition and 
prevent mental ill-health related to the DSD diagnosis.  
7.2 PSYCHIATRIC MORBIDITY IN WOMEN WITH DSD 
This thesis presents two unique studies on psychiatric morbidity in women with different 
forms of DSD. Study III is to date the largest population study on psychiatric morbidity in 
girls and women with CAH. Study IV is the first study to survey psychiatric disorders in 
women with DSD and women with POI and, in an age-matched population-derived control 
group by means of structured clinical interviews.  
The main findings from Study III were that girls and women with CAH had a higher lifetime 
incidence of any psychiatric disorder, including a doubled risk of alcohol misuse disorder, 
and twice the risk of stress related adjustment disorders when comparing with both male and 
female population controls. Similarly, the main findings in Study IV, were that women with 
DSD had a five times higher lifetime risk of satisfying the criteria for any psychiatric 
disorder, including past or recurrent mood disorders, anxiety disorders, and particularly 
obsessive-compulsive disorder (OCD), than population-derived controls.  
Previous research 
Psychiatric disorders among girls and women with DSD have been scarcely studied 
previously. Nonetheless, women with CAH, women with CAIS and women with GD have all 
ben found to have increased rates of psychiatric symptoms (105,107,118,119,194). The 
findings of an increased risk for anxiety disorders and substance misuse among girls and 
women with CAH have been demonstrated before, as well as higher risks among individuals 
with SW CAH, the most severe phenotype (120). In contrast, studies evaluating psychiatric 
disorders in women with CAIS show both impaired psychological functioning, e.g., 
psychological distress and suicidal tendencies (82,96,101,121), as well as equal, or even 
better, psychological functioning than in a reference group (47,107,195). The increased risk 
of mood disorder among women with CAIS and GD has been reported before 
(105,107,121,194). Given that CAIS and GD are more rare than CAH studies evaluating 
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mental health among women with DSD often have small samples, based on self-assessed 
instruments and with a lack control groups (196).  
Sex and gender differences 
What accounts for suboptimal psychological functioning in girls and women with DSD is 
most probably an interaction between different psychosocial and biological factors. There are 
well-documented gender differences in the incidence of mood and anxiety disorders with a 
doubled risk for women (197). This has been hypothesized to be related to the natural 
fluctuations in women’s sex hormones puberty, pregnancy, and menopause (198). However, 
there are similar trends regarding anxiety and depression when studying both women and 
men with CAH (199) which suggests that hormones might not be the full answer.  
There were no significant differences between women with POI and women with DSD or 
controls. Nonetheless, 76% of the women in Study IV fulfilled criteria for a lifetime 
psychiatric diagnosis. A POI diagnosis has previously been linked to an increase risk of 
depression, and that the POI diagnosis has a significant negative impact on quality of life, 
perceived stress, and psychological well-being (200,201). 
Anxiety disorders and exposure to stress 
Regarding anxiety, a doubled risk of a reaction to severe stress and adjustment disorders was 
shown to account for the increased risk in girls and women with CAH; however, no increased 
risk of OCD could be found in girls and women with CAH, contrary to women with CAIS 
and CGD.  
In addition, CAH is a complex metabolic condition and anxiety symptoms might be 
explained by dysregulation of the HPA–axis or adrenaline production that can lead to 
inabilities to regulate stress response (202) . It is known that CRH secretion increases if CAH 
is not treated optimally (203) and dysregulation of the HPA axis can be associated with 
anxiety, as well as depression and posttraumatic stress disorders (204). However, parents to 
children with CAH have showed high levels of posttraumatic stress symptoms and even 
though they are known carriers of one affected gene, a previous population study showed that 
CYP21A2 carriers are less vulnerable to psychological stress and had a reduced risk of having 
a psychiatric diagnosis (92,205). These findings suggest that genetic factors or social factors 
are not likely to mediate increased psychiatric morbidity in persons with CAH, suggesting 
that the diagnosis of CAH and the disease situation in itself is a mediator for stress 
symptoms.  
Similarly, stressful life events have been linked to the onset of OCD, and have also been 
suggested to predict the onset of depressive symptoms (206,207), Women with the XY 
karyotype report receiving the diagnosis in relation to impaired mental health (96). It is not 
farfetched to believe, that being diagnosed with a condition, such as a DSD and POI, which 
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overturns expectations concerning identity, fertility, and future health, can constitute a 
stressful life event. In line with this reasoning, women with an XY DSD have reported higher 
distress than individuals with other chronic disease (121). Women with DSD also describe 
possible traumatic events, such as bullying and repeated genital examinations (176,177), 
which may add to the increased vulnerability to psychiatric disorders. Social support and 
individual coping factors are known protective factors against developing psychiatric 
symptoms after a potentially traumatizing event (208), which further strengthens the 
incentives for giving psychological support to all parents and persons with a DSD, as well as 
broadening DSD knowledge in order to facilitate peer support.  
Potential mediators of psychiatric disorders 
Women with CAH have fecundity rates that are comparable to those of unaffected 
individuals and women with GD who have a uterus can become pregnant by means of an 
assisted zygote donation, but women with CAIS are infertile. Given that infertility is, 
irrespective of its cause, is associated with higher rates of depression, compared with the 
reported rates in fertile women (209), it is not unlikely that infertility can explain part of the 
high rates of psychological distress and depressive symptoms in women with POI (200). 
Infertility might also contribute to the psychological distress in women with DSD, but this 
has yet to be evaluated.  
CAH treatment consists of glucocorticoids in doses that attempt to mimic the physiological 
levels. It is known that higher doses of glucocorticoids are associated with depression and 
anxiety as well as mania and psychotic disorders (210). Since the Swedish Prescribed Drug 
Register has been in place since 2005 and does not cover drugs prescribed on license, aspects 
of treatment can not be assessed using this the study design in Study III, however, different 
glucocorticoid treatments have been shown to impair the quality of life in adult persons with 
CAH (211,212).  
Women with CAIS have reported feelings of decreased vitality after gonadectomy and, in 
addition, women with DSD report increased symptoms of fatigue which are suggested to be 
caused by a premature loss of gonadal functioning and a shift from testosterone driven 
hormonal balance to estrogen (51,195).  
In contrast to women with CAH, the primary treatment for women with CAIS, CGD, and 
POI is hormone replacement, often with combined contraceptives or hormone replacement 
therapy with e.g., ethinylestradiol (51,58). A recently published nationwide prospective 
Danish cohort study suggest that depression is an adverse effect of hormonal contraception 
therapy (213). This might be a contributor to the increased risk of depression in women 
with CAIS and the high numerical rates in POI.  
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Substance use disorders 
The high rates of substance use disorders among women with CAH were a striking find. 
Androgens are hypothesized to mediate alcohol addiction by sensitizing the brain's reward 
system for alcohol (214). Moreover, reward processing in CAH is suggested to be impaired 
due to androgen excess and cortisol impairment (215). Similarly, cortisol impairment because 
of a disturbed HPA-axis might lead to a overly sensitive stress system which, together with 
low levels of ACTH might increase the risk of developing alcoholism (216). Elevated ACTH 
levels can be found in women with CAH, particularly before the morning dose of 
glucocorticoids. On the other hand, replacement of glucocorticoids might results in decreased 
levels of ACTH (36). Moreover, alcohol might also be self-medication for coping with 
anxiety disorders or for living with a DSD condition. Women with the highest risk of alcohol 
misuse were women with the most severe null mutation, who have previously been reported 
to be most impaired with regard to the quality of life and psychosexual outcomes (87) 
However, increased risks of alcohol misuse disorders are also prevalent in men with CAH 
(199), which implies that addiction might be related to the physiology of CAH, or to 
psychosocial factors surrounding the condition. For example, men with CAH have also been 
exposed to repeated genital examinations pertaining to CAH since it is important to recognize 
the on-set of puberty, in order to evaluate whether signs of virilization are due to puberty or 
undertreatment of CAH, and there is also a non-negligible risk of testicular adrenal rest 
tumors in men with CAH. 
Psychiatric morbidity and the organizational hypothesis 
According to the organizational hypothesis, girls and women with CAH would display a 
panorama of psychiatric disorders comparable to that in male controls. However, the results 
from Study IV do not show results that can be explained by prenatal androgen effects.  
Androgens have been suggested to explain psychiatric disorder that are more usual in men, 
e.g., ADHD, autism, and substance misuse. The higher rates of substance misuse in Study III 
could have been suggested to be an androgenic effect, had it not been that the risk was also 
higher in male controls, as well as, in men with CAH (199). The theory of the extreme male 
brain stipulates that excessive androgens contribute to autism disorder could not be 
reproduced in this total population cohort, nor did the findings show an increased risk of 
ADHD. Moreover, girls and women with CAH also have an increased risk of conditions that 
are typically increased in women such as anxiety.  
In line with this reasoning and given that hormonal imbalance and XY chromosomes have 
been claimed to contribute to psychiatric symptoms, women with DSD would have a higher 
risk for psychiatric conditions, compared to women with POI and female controls. However, 
no conclusions can be drawn from study IV regarding the different hormonal milieus, neither 
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how congenital nor acquired hormonal imbalance affects the onset or trajectory of psychiatric 
disorders.  
This reflects the limitations of using such conditions as CAH as a form of natural 
experimentation because in medical conditions, such as CAH as in other examples of DSD 
(e.g., CAIS), other factors contribute to behavior, and it is reasonable to believe that the 
pathogenesis of mental health is multifactorial, involving both genetic and hormonal, as well 
as psychosocial factors (80). 
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7.3  METHODOLOGICAL CONSIDERATIONS 
Qualitative studies  
Studies I and II 
The major strength of the qualitative design is that it elucidates individual experiences, 
thoughts and perceptions concerning what it is like to have and live with CAH. This can 
contribute to a refined and deepened understanding in relation to women with CAH.  
However, qualitative methods cannot explain why there is variability in the patients’ 
experiences e.g., if it is due to a specific phenotype or genotype.  
Moreover, it is not possible to determine what is specific to CAH and what is specific to girls 
and women with CAH and which of these themes would also emerge if, for instance, men 
with CAH were interviewed or adults with very different chronic illnesses were interviewed. 
Certainly, some of the categories and themes that emerged from the content analysis might 
apply or be transferable to males, as well as to females: for example, affected boys undergo 
many genital exams because of concerns about precocious sexual development. However, 
this does not diminish the importance of these 13 women’s individual experience and what 
insight we can get from them. Nevertheless, conducting more qualitative research would be 
interesting since the patient perspective is important and might help us to understand what 
accounts for the variability in outcomes between individuals. 
Even though the sample size is considered to be adequate for qualitative studies it limits the 
transferability of the results (217). Thus, the results are not representative of all women with 
CAH, but that was never our intention when we started this project. Nevertheless, by 
recruiting women with different medical histories, with different birth years, and who have 
various experiences, we achieved rich data and this makes the findings transferable in the 
sense that they speak for more women than the 13 participants interviewed (132).   
Thirteen of 32 eligible women (41%) participated and the likelihood that the non-participants 
would be systematically different from those of the participants can be debated. Of course, 
there will be various experiences in a population but the non-participants and the participants 
were comparable regarding age, disease severity, medication and the number of surgeries, 
which might generate similar experiences, at least regarding interaction with health 
professionals.  
Nonetheless, an obvious limitation of the studies is the self-selected nature of the sample. The 
women who agreed to take part in this research are individuals who believe in the value of 
research. They were also coping with their condition well enough at the time of the 
interviews to have agreed to discuss experiences with a researcher. However, in qualitative 
research it is also important to recruit informants who are willing to share their experiences, 
to generate rich data (130,131).  
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When translating quotations from Swedish to English there is a risk that important nuances 
will go missing, since it is hard to find words that have the same cultural connotation in a 
different language. To counter this, we have made use of a native English speaker to confirm 
the appropriateness of our translations.  
As researchers with an interpretative approach wishes to find the individuals’ own definition 
of reality, these records are considered valid. Given that the answers and narratives in the 
interviews are their own explanations of events or their own understanding of their 
experiences. Moreover, researchers cannot always trust the participants’ accounts, but they 
can take the participants’ narratives as reflections of the underlying meanings.  
Quantitative studies  
Studies III and IV 
The primary strength of Study III was the use of a nationwide cohort, a population-based 
cohort of girls and women with CAH, with almost no loss to follow-up (20,39,199,218) and it 
is at present, also the largest published study on psychiatric morbidity in girls and women 
with CAH. Nevertheless, even though the inclusion in the National CAH Registry was based 
on all neonatal screening and CYP21A2 investigations, the accuracy of the diagnoses and the 
likelihood of missed diagnoses are currently unknown (20). In addition, since Sweden is a 
country with a small population and CAH is an uncommon condition, there is limited power 
because of a limited number of subjects who have received a psychiatric diagnosis in the 
registries. 
In Study IV, the strengths are the recruitment of a comparatively large number of patients 
and the use of the validated MINI+ semi-structured interview. However, CAIS and GD are 
very rare disorders and older individuals might not even have been diagnosed. Thus, we have 
recruited a relatively large sample, given the population of Sweden and the incidences of the 
disorders (1-9/100,000). Successful collaboration with clinicians and research midwifes and 
nurses, resulted in the participation of almost all of the known patients. The high participation 
rate ensures that even the most vulnerable patients, e.g., those with a current psychiatric 
morbidity participated in the study, thereby increasing the reliability of the results.  
Internal validity 
In epidemiological studies, the internal validity is classified as random errors or systematic 
errors. Random errors are related to problems with precision and are statistical fluctuations 
caused by chance or random variation in a study. Since we have only used a sample of the 
reference population, we cannot completely eliminate random errors. Thus, the best way to 
reduce random errors would be to increase the size of the study sample or to decrease 
variability in the measurements. Moreover, since random errors causes inaccurate measures 
of association we use statistical methods in assessing risk estimates in combination with the 
       58  
calculation of 95% confidence intervals (CI) with the aim of showing the degree of precision 
and the risk of random error. In both Studies III and IV, the results were considered to have 
occurred by chance if the 95% CI included 1, or p-values were above 0.05.  
Because of the numerically small subgroups in both Studies III and IV the analysis of the 
subgroups must be interpreted with caution. The failure to reach statistical significance for an 
association might well be due to low power rather than to a lack of association (type II error). 
This means that the association exists, although, given the small sample the testing will not 
be significant. Furthermore, given that we performed many different subgroup analyses, this 
might bring about a few significant results just by chance (type I error).  
Generally speaking, the power is good in the entire cohort of females with CAH, compared to 
their controls; therefore, the results regarding the most frequent psychiatric disorders can be 
considered to be informative in Study III. Even though the subgroups are small, we believe it 
is interesting to report on the different subgroups since they differ quite a lot clinically. 
Moreover, the results are similar to those for the boys and men with CAH, which we think 
strengthens our results despite the low number of individuals and a small number of subjects 
with a psychiatric diagnosis (122). This may also give rise to new hypothesis, which can be 
investigated further in future studies. 
A register-based methodology cannot resolve the issue concerning what accounts for the 
differences between genotypes with respect to the risk of psychiatric disorders. If we were to 
compare the genotype groups with each other, we would have to adjust for age, where they 
live in Sweden, and migration since this give different opportunities for specialist care, and 
we cannot adjust for these things with low number of individuals. Thus, a clinical study 
where individuals with CAH with different genotypes are prospectively interviewed by 
standardized diagnostic interviews (e.g., MINI+) would be a more appropriate approach.   
External validity 
Given the young cohort of patients in Study IV with a median age of 25 years in January 
2010, the results describe psychiatric diagnosis with onset from childhood up to young 
adulthood. The young median age is explained by increased survival rates after the 
introduction of glucocorticoids in the 1950s and the implementation of the neonatal screening 
program in 1986 (20). Thus, with a longer follow-up period the results may change  
Reliability of the data 
In Study III misclassification of psychiatric disorders in the registries might lead to affected 
individuals being classified as not affected (false negative) and not affected individuals being 
classified as affected (false positive).  In addition, the diagnostic criteria for the psychiatric 
disorders are based on specified clinical symptoms and the diagnoses rely on the 
ascertainment of the treating physicians. Since there are no biomarkers for most psychiatric 
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disorders, the risk of misclassification is high and the accuracy of the diagnoses have been 
examined in validation studies. No study has yet validated all psychiatric DSM codes in the 
inpatient registry: however, the validity for bipolar disorders has been found to be sufficiently 
sensitive and specific to be used in an epidemiological study (219).  
The use of MINI+ in Study IV provided an objective survey of psychiatric disorders in 
comparison to self reported measures. However, the interviewers were not blinded to the 
purpose of the study, but the use of a structured diagnostic interview performed by clinically 
trained physicians decreases the potential self-reported bias. The credibility of the results is 
strengthened by the fact that every one who stated a previous contact with the healthcare 
services due to psychiatric symptoms also fulfilled the diagnostic criteria according to the 
MINI-screening.  
In Study III there is also a risk of an ascertainment bias since girls and women with CAH 
might have more healthcare contacts because of their condition they might be more likely to 
receive a psychiatric diagnosis than persons without CAH. Moreover, in Study IV there is a 
risk of a recall bias since the data on psychiatric symptoms were collected retrospectively 
(lifetime psychiatric disorders), in addition to current symptoms of a psychiatric disorder. 
Thus, the quality of the data is determined according to the ability of the individual to recall 
past symptoms. This may result in an under- or overestimation of the association between 
exposure (having a DSD) and outcome (psychiatric morbidity).  
Selection bias consists of systematic differences in including patients and controls. This type 
of bias may be present in Study IV since we do not have data on the patients who did not 
participate. By virtue of the study design, i.e., using face-to-face interviews, persons who are 
socially well adjusted will be more prone to volunteer. Regarding controls, it is known that 
individuals who volunteer are not likely to be representative of the general population; 
however, we have attempted to limit the bias by recruiting from the Total Population Registry 
and matching by date and year of birth. A selection bias among those who volunteered is 
possible, e.g., 31% of the population-derived controls have had treatment for psychiatric 
symptoms, which was almost twice as high as in a Swedish epidemiological study from 2013 
(220). 
A confounder is an external variable in a statistical model that directly or inversely correlates 
with both the dependent and the independent variable. In Study III we adjusted for the 
parents’ highest level of education as a proxy for socioeconomic status, since socioeconomic 
status could affect treatment of CAH and could also contribute to psychiatric morbidity. In 
addition, mediators explain the relationships between the dependent and the independent 
variable. In Study III, stress could be suggested to be a mediator.  
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8 IMPLICATIONS AND FUTURE DIRECTIONS 
The studies in this thesis imply that there are some things that can be done by clinicians, 
researchers, individuals with DSD, and society. They also point toward future research areas 
to pursue.  
Clinical implications 
The most important clinical implication of the studies in this thesis is that clinicians who meet 
women with DSD should appreciate that these women are a diverse group of individuals, 
with different experiences, wishes, and outlooks on life, and that they all have shifting 
perspectives on what role their DSD plays in their lives. Experiences are hard to understand 
and therefore it is important to include the patients in management and decisions. Secondly, 
women with different DSD are at high-risk for developing psychiatric disorders, especially 
affective disorders, anxiety disorders and addiction. This warrants attention to psychiatric 
symptoms in clinical follow-up.  
Parents are an important source of information. Parental support and, later, peer support, are 
important for children and adults coping with DSD conditions. Thus, psychosocial and 
psychiatric outcomes for women with CAH women may be improved by psychological 
support given to parents. In addition, support to facilitate disclosure to peers including age- 
appropriate knowledge and specific information at transitions in order to counteract such 
myths as “My children will not be healthy”.  
To counteract feelings of exposure and limit potential traumatic experiences, both these and 
other studies highlights that only medically indicated genital examinations should be 
performed, after consent, and with as few persons as possible involved.  
Challenging preconceptions 
As clinicians and researchers, it is very important to be aware of the predominant medical 
discourse with a positivistic stance implying that there is one truth and one ultimate way to do 
the right thing. In this discourse, normal is seen as being most typical or within the standard 
deviation. By being of aware of this, we can help individuals with DSD to navigate through 
the medical discourse and broaden the concept of normality. It is also important to question 
our own normative preconceptions before we meet the patients and before we analyze our 
research results. Results might not always be best explained by a DSD; however, they might 
be mediated through experiences and consequences of living with a DSD.  
Findings in this thesis and other studies support the notion that individuals with DSD would 
be helped by raised public awareness concerning DSD and a knowledge of the variations in 
bodies and differences in sex development. This may help persons with DSD to challenge 
assumptions concerning ‘normal’ bodies and also add DSD to people’s general knowledge.  
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Future directions 
There is a need to evaluate the impact of clinical management on DSD and to assess the long-
term outcomes in large unbiased cohorts, both for the sake of persons with DSD and their 
parents. Furthermore, it would be interesting to know what it is that may account for the 
variability in individuals’ experiences since this might lead us to the development of 
interventions to optimize health-related quality of life outcomes. In the same way, it would be 
interesting to assess the impact of peer support and patient support groups on psychological 
adjustment and the QoL with a life-long chronic condition. In addition, studying the 
prevalence of stressful or traumatic life events and their impact on adjustment and the QoL 
could provide us with further implications for future care. Lastly, in order to guide future 
research, it is important to include the parents’ and the affected individuals’ opinions about 
what outcomes are important from their perspective. Moreover, persons with DSD and their 
parents can aid in the design of studies by evaluating the choice of words and improving the 
language related to research on DSD. 
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9 CONCLUSIONS 
The aim of this thesis was to investigate psychological and psychiatric aspects in women with 
DSD, which ultimately give insights into how the care for children and adults can be 
optimized. These findings give support to the notion that psychological and psychiatric 
aspects in individuals with DSD are important and need to be prioritized in clinical 
management. In particular, this thesis shows that women with DSD are individuals with 
different experiences and needs. Further, women with DSD have increased risk of psychiatric 
disorders. This highlights the need for clinical attention to psychiatric symptoms among these 
persons. Clinical treatment and management strategies of women with DSD need continual 
evaluation to possibly mitigate psychiatric morbidity and psychological challenges. The 
perspective of women with DSD shed light on how clinical management of these patients 
have been developed, mainly from a medical perspective, however, to more successfully 
address the challenges these women experience, their perspective needs to be further 
investigated in future research.  
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10  PERSONAL REFLECTIONS 
Doctoral education comprises four years filled with new knowledge, insight, frustration, 
challenges, laughter, and coffee, which will hopefully result in a doctoral degree (PhD). 
Given that it is an education, I thought that I would take this opportunity to reflect upon what 
I have learnt.  
The studies that make up this thesis were conducted to achieve the overarching research aims. 
In addition, they were also chosen to make the doctoral education as rewarding as possible. 
Three out of the four studies apply to different methods and given that they are all complex, I 
cannot claim to be an expert in any of them. However, I do know the possibilities and the 
limitations of these methods, and I have learned that the most important thing is to ask for 
help. We also chose to include studies that would not only have a variation of methods, but 
also different sampling methods in order to give me the opportunity to learn how to recruit 
research subjects and controls. For Study IV we had our research reception on Fridays at 
Kvinnohälsan at the Karolinska University Hospital. Since the DSD conditions are rare and 
patients are, just like everyone else, busy, the data collection was, to say the least, time-
consuming. Some Fridays all the research personnel were there, in total 5-6 individuals, but 
no research subjects showed up.  
The fact that these conditions are rare makes it hard to recruit subjects but also to use 
statistics if you also want significance in your findings. It is known that with larger groups, it 
is easier to find significance. Regarding Study IV we could, of course, have included patients 
for several years to come to in order to reach statistical significance in all groups, since it 
always feels good, personally, when the p is smaller than 0.05. However the importance of 
the findings are not always determined by statistical significance. Because, during this 
project, I have, learned that not everything that can be counted counts, and everything that 
counts cannot always be counted! 
Moreover, one of the biggest challenges during this project was to publish the first qualitative 
manuscript (Study I). It turned out that it was hard being in a medical context trying to 
publish a qualitative study on psychological aspects. It was either too psychological or not 
psychological enough. After seven subsequent rejects, we decided that the most important 
thing was that clinicians read our findings, so I rewrote the manuscript for a medical journal 
aimed at endocrinologist, and in this case, the eight time was the charm. 
In conclusion, I have learned that research is fun, frustrating and, there is no such thing as the 
perfect study. However, I hope that the findings in this thesis can contribute in some way to 
improved caretaking of individuals with DSD. It will probably never be unproblematic to 
have a chronic condition that also affects the appearance of the body, but I hope that the 
confidence interval for normality will become broader and thus make it easier for everyone to 
feel “normal”.  
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